<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0176631</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-40380</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Neuromuscular diseases</subject><subj-group><subject>Fibromyalgia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Rheumatology</subject><subj-group><subject>Fibromyalgia</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin D</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin D</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical compounds</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin E</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Organic chemistry</subject><subj-group><subject>Organic compounds</subject><subj-group><subject>Vitamins</subject><subj-group><subject>Vitamin E</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Chemistry</subject><subj-group><subject>Chemical elements</subject><subj-group><subject>Magnesium</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Neurology</subject><subj-group><subject>Neuromuscular diseases</subject><subj-group><subject>Chronic fatigue syndrome</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Rheumatology</subject><subj-group><subject>Chronic fatigue syndrome</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research design</subject><subj-group><subject>Observational studies</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Vitamin and mineral status in chronic fatigue syndrome and fibromyalgia syndrome: A systematic review and meta-analysis</article-title>
<alt-title alt-title-type="running-head">Vitamins and minerals in chronic fatigue syndrome and fibromyalgia syndrome</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Joustra</surname>
<given-names>Monica L.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Minovic</surname>
<given-names>Isidor</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Janssens</surname>
<given-names>Karin A. M.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bakker</surname>
<given-names>Stephan J. L.</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Rosmalen</surname>
<given-names>Judith G. M.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Interdisciplinary Center Psychopathology and Emotion regulation, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Top Institute Food and Nutrition, Wageningen, the Netherlands</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Lee</surname>
<given-names>Jung Eun</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Seoul National University, REPUBLIC OF KOREA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>S.J.L.B. obtained grants from DSM and Friesland Campina, and S.J.L.B. and I.M. obtained funding from the Top Institute Food and Nutrition (TIFN, grants CH-001 and CH-003, respectively). This does not alter our adherence to PLOS ONE policies on sharing data and materials. We would like to emphasize that all aspects of this review were objectively assessed, and that all authors involved have acted conscientiously. The other authors declare that they have no known conflicts of interest.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"><list-item>
<p><bold>Conceptualization:</bold> MLJ IM KAMJ SJLB JGMR.</p></list-item> <list-item>
<p><bold>Data curation:</bold> MLJ IM JGMR.</p></list-item> <list-item>
<p><bold>Formal analysis:</bold> MLJ.</p></list-item> <list-item>
<p><bold>Funding acquisition:</bold> MLJ.</p></list-item> <list-item>
<p><bold>Investigation:</bold> MLJ IM.</p></list-item> <list-item>
<p><bold>Methodology:</bold> MLJ JGMR.</p></list-item> <list-item>
<p><bold>Project administration:</bold> MLJ.</p></list-item> <list-item>
<p><bold>Resources:</bold> MLJ.</p></list-item> <list-item>
<p><bold>Supervision:</bold> JGMR KAMJ SJLB.</p></list-item> <list-item>
<p><bold>Validation:</bold> MLJ IM JGMR.</p></list-item> <list-item>
<p><bold>Visualization:</bold> MLJ.</p></list-item> <list-item>
<p><bold>Writing – original draft:</bold> MLJ.</p></list-item> <list-item>
<p><bold>Writing – review &amp; editing:</bold> MLJ IM KAMJ SJLB JGMR.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">m.l.joustra@umcg.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>28</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>4</issue>
<elocation-id>e0176631</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>10</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Joustra et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0176631"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>Many chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS) patients (35–68%) use nutritional supplements, while it is unclear whether deficiencies in vitamins and minerals contribute to symptoms in these patients. Objectives were (1) to determine vitamin and mineral status in CFS and FMS patients as compared to healthy controls; (2) to investigate the association between vitamin and mineral status and clinical parameters, including symptom severity and quality of life; and (3) to determine the effect of supplementation on clinical parameters.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>The databases PubMed, EMBASE, Web of Knowledge, and PsycINFO were searched for eligible studies. Articles published from January 1<sup>st</sup> 1994 for CFS patients and 1990 for FMS patients till March 1<sup>st</sup> 2017 were included. Articles were included if the status of one or more vitamins or minerals were reported, or an intervention concerning vitamins or minerals was performed. Two reviewers independently extracted data and assessed the risk of bias.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>A total of 5 RCTs and 40 observational studies were included in the qualitative synthesis, of which 27 studies were included in the meta-analyses. Circulating concentrations of vitamin E were lower in patients compared to controls (pooled standardized mean difference (SMD): -1.57, 95%CI: -3.09, -0.05; p = .042). However, this difference was not present when restricting the analyses to the subgroup of studies with high quality scores. Poor study quality and a substantial heterogeneity in most studies was found. No vitamins or minerals have been repeatedly or consistently linked to clinical parameters. In addition, RCTs testing supplements containing these vitamins and/or minerals did not result in clinical improvements.</p>
</sec>
<sec id="sec004">
<title>Discussion</title>
<p>Little evidence was found to support the hypothesis that vitamin and mineral deficiencies play a role in the pathophysiology of CFS and FMS, and that the use of supplements is effective in these patients.</p>
</sec>
<sec id="sec005">
<title>Registration</title>
<p>Study methods were documented in an international prospective register of systematic reviews (PROSPERO) protocol, registration number: <ext-link ext-link-type="uri" xlink:href="http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015032528" xlink:type="simple">http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015032528</ext-link>.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>S.J.L.B. obtained grants from DSM and Friesland Campina, and S.J.L.B. and I.M. obtained funding from the Top Institute Food and Nutrition (TIFN, grants CH-001 and CH-003, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="4"/>
<page-count count="25"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec006" sec-type="intro">
<title>Introduction</title>
<p>Chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS) are syndromes of unknown origin. The core symptom of CFS is profound disabling fatigue [<xref ref-type="bibr" rid="pone.0176631.ref001">1</xref>], whereas FMS is characterized by chronic widespread pain [<xref ref-type="bibr" rid="pone.0176631.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0176631.ref003">3</xref>]. CFS and FMS are known for substantial clinical and diagnostic overlap, for example, chronic pain and fatigue are common in both patient groups. The two syndromes are often comorbid; up to 80% of CFS patients reported a history of clinician-diagnosed FMS [<xref ref-type="bibr" rid="pone.0176631.ref004">4</xref>,<xref ref-type="bibr" rid="pone.0176631.ref005">5</xref>]. This has resulted in the hypothesis that these syndromes share etiological pathways [<xref ref-type="bibr" rid="pone.0176631.ref006">6</xref>].</p>
<p>Vitamin and mineral deficiencies may play a role in the pathophysiology of both CFS and FMS, although mechanisms behind this hypothesis are not entirely clear [<xref ref-type="bibr" rid="pone.0176631.ref007">7</xref>,<xref ref-type="bibr" rid="pone.0176631.ref008">8</xref>]. In addition, results of studies investigating the effects of nutritional supplementation or dietary intake on, for example, symptom severity in these patient groups, are conflicting [<xref ref-type="bibr" rid="pone.0176631.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0176631.ref012">12</xref>]. Nevertheless, a large proportion of CFS and FMS patients indicate they use nutritional supplements (35%-68%) [<xref ref-type="bibr" rid="pone.0176631.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0176631.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0176631.ref015">15</xref>], compared to the Dutch general population (27–56%) [<xref ref-type="bibr" rid="pone.0176631.ref016">16</xref>]. The higher nutritional supplement use among patients may be due to encouragements by specialty stores, the internet or (complementary medicine) clinics. Vitamins and minerals in these products are sometimes supplemented in doses high enough to cause health problems, for example gastric discomfort, insomnia, dizziness and weakness [<xref ref-type="bibr" rid="pone.0176631.ref017">17</xref>]. More information is needed on the evidence for (marginal) vitamin and mineral deficiencies in CFS and FM, and the potential benefits in taking nutritional supplements.</p>
<p>Recently, a review investigating hypovitaminosis D in both chronic pain and FMS patients showed that these patients were at significantly higher risk of hypovitaminosis D than healthy controls [<xref ref-type="bibr" rid="pone.0176631.ref018">18</xref>]. Unfortunately, further reviews on vitamin and mineral deficiencies among CFS and FMS patients are lacking. We therefore carried out this first systematic review on vitamin and mineral status in CFS and FMS. We explored the following research questions: first, what is the evidence for deficiencies in vitamin and mineral status in CFS and FMS patients as compared to healthy controls? Second, is vitamin and mineral status associated with clinical parameters, including symptom severity and quality of life, in CFS and FMS? Third, what is the evidence for an effect of vitamin and mineral supplementation, as compared to placebo, on clinical parameters in CFS and FMS patients? Because it is currently unknown whether CFS and FMS result from the same etiology, we analyzed results both for the combined and for the separate syndromes.</p>
</sec>
<sec id="sec007" sec-type="materials|methods">
<title>Methods</title>
<p>We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (<xref ref-type="supplementary-material" rid="pone.0176631.s001">S1 Table</xref>) [<xref ref-type="bibr" rid="pone.0176631.ref019">19</xref>]. Prior to start of article inclusion, we documented study methods in an international prospective register of systematic reviews (PROSPERO) protocol, registration number: CRD42015032528, <ext-link ext-link-type="uri" xlink:href="http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015032528" xlink:type="simple">http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015032528</ext-link>.</p>
<sec id="sec008">
<title>Data sources and searches</title>
<p>The databases PubMed, EMBASE, Web of Knowledge, and PsycINFO were systematically searched. Articles published between January 1<sup>st</sup> 1994 and 1990, for CFS and FMS respectively, and March 1<sup>st</sup> 2017 were included. We focused on the most recent diagnostic guidelines, namely the International Center of Disease Control (CDC) diagnostic criteria for CFS that was established in 1994 [<xref ref-type="bibr" rid="pone.0176631.ref001">1</xref>], and the American College of Rheumatology (ACR) criteria for FMS in 1990 [<xref ref-type="bibr" rid="pone.0176631.ref002">2</xref>]. To retrieve relevant articles from PubMed, we formulated a search string (<xref ref-type="supplementary-material" rid="pone.0176631.s002">S1 Appendix</xref>) that consisted of CFS, FMS, and synonyms, vitamins, minerals, micronutrients and synonyms, while excluding systematic reviews or animal studies. This search string was adapted according to the thesaurus of the databases EMBASE, Web of Knowledge, and PsycINFO. All included studies were screened for potential references that were not included in the first search. Duplicates were removed, as well as studies including pediatric participants. There were no language restrictions; included non-English articles were translated (French, Italian, Polish, and Turkish articles) by native speakers.</p>
</sec>
<sec id="sec009">
<title>Study selection</title>
<p>Title and abstract were screened by two independent reviewers (M.L.J. and I.M.) for the following criteria: (1) CFS or FMS patients; (2) vitamin or mineral status; and (3) study design. Studies which were in agreement with the eligibility criteria were retrieved as full text. Discrepancies between the two researchers were resolved by consensus, and when needed a third assessor was consulted (J.G.M.R.). Reasons for exclusion and percentage of agreement, as Cohen’s kappa, between the assessors were documented.</p>
<p>Participants of the included studies had to be adults (i.e. ≥18 years) suffering from CFS or FMS according to the official diagnostic criteria [<xref ref-type="bibr" rid="pone.0176631.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0176631.ref003">3</xref>]. Studies that involved patients with a combination of CFS and FMS or other comorbid medical conditions were excluded. Furthermore, the vitamin or mineral status had to be assessed or reported in the article, or there had to be an intervention concerning vitamins or minerals. Patients were compared with healthy controls in observational studies, or vitamin and mineral supplementation were compared with placebo in intervention studies. Lastly, cross-sectional studies comparing cases and controls, cohort studies and randomized controlled trials (RCTs) were included. Case reports, clinical cohorts without appropriate controls (e.g. controls with musculoskeletal pain or fatigue), (systematic) reviews, expert opinion, and other study designs were excluded.</p>
</sec>
<sec id="sec010">
<title>Data extraction</title>
<p>Two reviewers (M.L.J. and I.M.) independently extracted data and assessed the risk of bias for each study. The first ten articles were screened together to pilot the data extraction and risk of bias form. Reasons for exclusion and percentage of agreement between the assessors were documented.</p>
<p>From the included articles, the following information was extracted: name first author, publication year, type FSS, number and age of the participants, and vitamin or mineral status. In addition, data on smoking habits or alcohol use, diet (and assessment tool used), BMI (or waist circumference, waist-hip ratio), physical activity (assessment tool), socioeconomic status, ethnicity, severity of illness (assessment tool), duration of illness, co-morbidities (somatic and psychiatric), medication use, clinical parameters including symptom severity and quality of life, and in case of RCTs the relevant co-intervention(s) were also extracted.</p>
</sec>
<sec id="sec011">
<title>Quality assessment</title>
<p>To assess quality of RCTs, the Cochrane Collaboration’s tool for assessing risk of bias was employed [<xref ref-type="bibr" rid="pone.0176631.ref020">20</xref>]. For observational studies, literature indicates lack of a single methodological assessment tool [<xref ref-type="bibr" rid="pone.0176631.ref021">21</xref>,<xref ref-type="bibr" rid="pone.0176631.ref022">22</xref>]. Therefore, we adjusted a previously developed quality tool for observational studies in this field [<xref ref-type="bibr" rid="pone.0176631.ref023">23</xref>], for use in studies that focus specifically on the association between vitamin and mineral status and CFS or FMS. Eight of the nine items in this original quality tool originated from guidelines or tools for either reporting or appraising observational research [<xref ref-type="bibr" rid="pone.0176631.ref024">24</xref>–<xref ref-type="bibr" rid="pone.0176631.ref026">26</xref>]. These items were adjusted to the specific question on vitamins and minerals and classified into three key domains: appropriate selection of participants (validated disorder, representative controls, in- and exclusion criteria, disease characteristics), appropriate quantification of vitamin and mineral status (duplicate quantification, appropriate outcome), and appropriate control for confounding (assessed confounders, analyses adjusted). The item: “Is the assessor blind for disease status”, was excluded since from the original quality tool since it is not applicable in the current review. Furthermore, we added the item “Are methods for assessment of vitamin and mineral status clearly stated”, based on the adapted Newcastle Ottawa scale for cross-sectional studies (<xref ref-type="supplementary-material" rid="pone.0176631.s003">S2 Appendix</xref>) [<xref ref-type="bibr" rid="pone.0176631.ref027">27</xref>]. RCTs that contained relevant observational data (n = 4/5), were assessed with both the Cochrane tool and the observational studies quality tool. For both quality tools, items were rated as (0) low risk, (1) medium risk, and (2) high risk of bias. The maximum attainable quality score was 14 for RCTs, and 18 for observational studies.</p>
</sec>
<sec id="sec012">
<title>Data synthesis and analysis</title>
<p>We first constructed an overview of available data on the different vitamins and minerals. Characteristics of the included studies were systematically listed to generate a clear overview of the current literature on vitamins and minerals in CFS and FMS patients. For those vitamins and minerals with more than five studies available, we did quantitative syntheses on aggregated data. For these syntheses, data was pooled with the random effects model of meta-analysis, using Stata statistical software, version 14 (Statacorp LP, Texas). To allow pooling across studies that used different outcomes of vitamin or mineral plasma or serum levels, we calculated the standardized mean difference (SMD). For proportions of deficiencies, the odds ratio (OR) was calculated and pooled. Subsequently, the SMD and OR for each study were weighted by their inverse variance and the corresponding 95%CI were calculated. The existence of heterogeneity among studies was assessed by Q-tests, and the degree of the heterogeneity was quantified by calculating the I-squared (I<sup>2</sup>) value. Publication bias was inspected visually by a funnel plot, and an Egger’s test was conducted to quantify funnel plot asymmetry [<xref ref-type="bibr" rid="pone.0176631.ref028">28</xref>]. The Tweedie’s Trim and Fill test was performed as an additional sensitivity analysis to identify and correct for funnel plot asymmetry arising from publication bias [<xref ref-type="bibr" rid="pone.0176631.ref029">29</xref>]. When the Trim and Fill test was performed, and additional studies were added to the analyses, contour-enhanced funnel plots were used instead of regular funnel plots to examine whether asymmetry in the funnel plots was due to publication bias [<xref ref-type="bibr" rid="pone.0176631.ref030">30</xref>]. Subgroup analyses were performed including studies with more than half of the maximum study quality score (&gt;9 quality points), if more than three studies with a sufficient quality score were available. Furthermore, vitamin and mineral status of CFS and FMS patients were investigated separately if more than three studies were available. Findings were considered statistically significant if P&lt;0.05.</p>
</sec>
</sec>
<sec id="sec013" sec-type="results">
<title>Results</title>
<sec id="sec014">
<title>Study inclusion</title>
<p>Results of the systematic review and meta-analysis are presented in a flow diagram (<xref ref-type="fig" rid="pone.0176631.g001">Fig 1</xref>). Cohen’s kappa’s for the abstract and full text selection were 0.96 and 0.89 respectively, indicating very good consistency of agreement [<xref ref-type="bibr" rid="pone.0176631.ref031">31</xref>]. Out of 108 studies included for the full text review, 45 studies were included in the current review.</p>
<fig id="pone.0176631.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.g001" xlink:type="simple"/>
</fig>
<p>Characteristics of the included studies are presented in <xref ref-type="table" rid="pone.0176631.t001">Table 1</xref>, and results of the quality assessment in Tables <xref ref-type="table" rid="pone.0176631.t002">2</xref> and <xref ref-type="table" rid="pone.0176631.t003">3</xref>. Most studies involved FMS patients (n = 35/45); 4 of the 5 RCTs also contained relevant observational data. Vitamin and mineral status was mainly assessed in plasma or serum (n = 40/45). Furthermore, quality scores revealed poor study quality (i.e. equal or less than half of the maximum study quality score) in the vast majority of observational studies (n = 27/44; range 4–14 points) and RCTs (n = 3/5; range 5–12 points). Only few observational studies defined all described in- and exclusion criteria for the investigated population, including medication use, somatic morbidity, and psychiatric morbidity (n = 10/44). The CFS or FMS diagnostic criteria were often described in observational studies, but researchers failed to state whether or not the syndromes were diagnosed by a physician (n = 40/44). Disease characteristics were frequently not fully presented (n = 15/44), or were completely absent (n = 18/44) in observational studies. Almost all observational studies did not assess vitamin or mineral in duplicate (n = 38/44). Most studies that assessed vitamin or mineral status did not clearly state the methods for assessment of vitamin and mineral status (n = 27/44). Furthermore, most observational studies did not adjust their analyses for any potential confounders (n = 43/44). Lastly, most RCTs had a medium to high risk of bias for random sequence generation (n = 3/5), allocation concealment (n = 3/5), blinding of outcome assessment (n = 4/5), incomplete data (n = 4/5), selective reporting quantification (n = 3/5), and other bias (n = 5/5).</p>
<table-wrap id="pone.0176631.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of included studies.</title></caption>
<alternatives>
<graphic id="pone.0176631.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<tbody>
<tr>
<td align="left"><bold>Study</bold></td>
<td align="left"><bold>Setting</bold></td>
<td align="left"><bold>Type of FSS</bold></td>
<td align="left"><bold>N of cases</bold></td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>Mean age in years (SD)</bold></td>
<td align="left"><bold>Mean FSS severity (SD) and/or mean duration in months (SD)</bold></td>
<td align="left"><bold>Comparison group (n)</bold></td>
<td align="left"><bold>Vitamin and/or mineral</bold></td>
<td align="left"><bold>Material</bold></td>
</tr>
<tr>
<td align="left"><bold>Akkus et al, 2009</bold> [<xref ref-type="bibr" rid="pone.0176631.ref032">32</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">30</td>
<td align="left">Case-control</td>
<td align="left">40.1 (5.2)</td>
<td align="left">FIQ: 59.8 (7.9)<break/>68.8</td>
<td align="left">Healthy controls (30)</td>
<td align="left">Vitamin A, C, E</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Al-Allaf et al, 2003</bold> [<xref ref-type="bibr" rid="pone.0176631.ref033">33</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">40</td>
<td align="left">Case-control</td>
<td align="left">42.5 (3.6)</td>
<td align="left">FIQ (score out of 10):<break/> 6.5 (2.2)<break/>48 (31)</td>
<td align="left">Healthy controls (37)</td>
<td align="left">Vitamin D, calcium</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Bagis et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref034">34</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">60</td>
<td align="left">RCT and case-control</td>
<td align="left">40.7 (5.2)</td>
<td align="left">FIQ:<break/> 38.8 (10.4)</td>
<td align="left">Healthy controls (20)</td>
<td align="left">Magnesium</td>
<td align="left">Serum, erythrocytes</td>
</tr>
<tr>
<td align="left"><bold>Baygutalp et al, 2014</bold> [<xref ref-type="bibr" rid="pone.0176631.ref035">35</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">19</td>
<td align="left">Case-control</td>
<td align="left">35 (7.5)</td>
<td align="left">FIQ:<break/> 19.3 (21.5)<break/>4.4 (1.2)</td>
<td align="left">Healthy controls (21)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Bazzichi et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref036">36</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">25</td>
<td align="left">Case-control</td>
<td align="left">48.8 (9.3)</td>
<td align="left">FIQ: 57.9 (17.3)</td>
<td align="left">Secondary care patients without FM or musculo-skeletal pain (25)</td>
<td align="left">Calcium, magnesium</td>
<td align="left">Platelets</td>
</tr>
<tr>
<td align="left"><bold>Brouwers et al, 2002</bold> [<xref ref-type="bibr" rid="pone.0176631.ref037">37</xref>]</td>
<td align="left">Tertiary care</td>
<td align="left">CFS</td>
<td align="left">24</td>
<td align="left">RCT</td>
<td align="left">40.0 (9.9)</td>
<td align="left">CIS: 51.4 (4.2) Disease duration (years, median (IQR)) 8.0 (2–15)</td>
<td align="left">Placebo, CFS patients (25)</td>
<td align="left">Polynutrient supplement</td>
<td align="left">NA</td>
</tr>
<tr>
<td align="left"><bold>Costa et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref038">38</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">100</td>
<td align="left">Case-control</td>
<td align="left">42.4 (8.4)</td>
<td align="left">NR</td>
<td align="left">Healthy controls (57)</td>
<td align="left">Calcium</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Eisinger et al, 1997</bold> [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">25</td>
<td align="left">Case-control</td>
<td align="left">40</td>
<td align="left">NR</td>
<td align="left">Healthy controls (20)</td>
<td align="left">Vitamin A, E, magnesium, selenium, zinc</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Eisinger et al, 1996</bold> [<xref ref-type="bibr" rid="pone.0176631.ref040">40</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">25</td>
<td align="left">Case-control</td>
<td align="left">40</td>
<td align="left">NR</td>
<td align="left">Healthy controls (20)</td>
<td align="left">Magnesium</td>
<td align="left">Serum, erythrocytes, lencocytes</td>
</tr>
<tr>
<td align="left"><bold>Study</bold></td>
<td align="left"><bold>Setting</bold></td>
<td align="left"><bold>Type of FSS</bold></td>
<td align="left"><bold>N of cases</bold></td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>Mean age in years (SD)</bold></td>
<td align="left"><bold>Mean FSS severity (SD) and/or mean duration in months (SD)</bold></td>
<td align="left"><bold>Comparison group (n)</bold></td>
<td align="left"><bold>Vitamin and/or mineral</bold></td>
<td align="left"><bold>Material</bold></td>
</tr>
<tr>
<td align="left"><bold>Heidari et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref041">41</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">17</td>
<td align="left">Case-control</td>
<td align="left">40.6 (8.3)</td>
<td align="left">NR</td>
<td align="left">Secondary care patients without FM or musculoskeletal pain (202)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Jammes et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref042">42</xref>]</td>
<td align="left">NR</td>
<td align="left">CFS</td>
<td align="left">5</td>
<td align="left">Case-control</td>
<td align="left">39 (8)</td>
<td align="left">72 (12)</td>
<td align="left">Healthy controls (23)</td>
<td align="left">Vitamin C, potassium, sodium</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Jammes et al, 2009</bold> [<xref ref-type="bibr" rid="pone.0176631.ref043">43</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">CFS</td>
<td align="left">18</td>
<td align="left">Case-control</td>
<td align="left">38 (5)</td>
<td align="left">NR</td>
<td align="left">Medical checkup patients (9)</td>
<td align="left">Vitamin C</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Kasapoğlu Aksoy et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref044">44</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">53</td>
<td align="left">Case-control</td>
<td align="left">48.2 (9.6)</td>
<td align="left">VAS pain (0–10) median, min-max: 8.0 (4.0–10.0)</td>
<td align="left">Healthy controls (47)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Khalifa et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref045">45</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">31</td>
<td align="left">Case-control</td>
<td align="left">40.2 (13.3)</td>
<td align="left">FIQR mean: 32.4</td>
<td align="left">Healthy controls (21)</td>
<td align="left">Calcium, copper, magnesium, zinc</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">44</td>
<td align="left">Case-control</td>
<td align="left">42.5 (6.9)</td>
<td align="left">NR</td>
<td align="left">Healthy controls (122)</td>
<td align="left">Calcium, copper, ferritin, magnesium, manganese, phosphorus, potassium, selenium, sodium, zinc</td>
<td align="left">Hair</td>
</tr>
<tr>
<td align="left"><bold>Kurup et al, 2003</bold> [<xref ref-type="bibr" rid="pone.0176631.ref047">47</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">CFS</td>
<td align="left">15</td>
<td align="left">Case-control</td>
<td align="left">30–40 range</td>
<td align="left">NR</td>
<td align="left">Healthy controls (15)</td>
<td align="left">Vitamin E, magnesium</td>
<td align="left">Plasma, RBC</td>
</tr>
<tr>
<td align="left"><bold>La Rubia et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>]</td>
<td align="left">NA</td>
<td align="left">FMS</td>
<td align="left">45</td>
<td align="left">Case-control</td>
<td align="left">52.2 (7.5)</td>
<td align="left">FIQ: 61.4 (13.1)</td>
<td align="left">Healthy controls (25)</td>
<td align="left">Copper, ferritin, iron, zinc</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Maafi et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>]</td>
<td align="left">Tertiary care</td>
<td align="left">FMS</td>
<td align="left">74</td>
<td align="left">Case-control</td>
<td align="left">37.9 (9.8)</td>
<td align="left">FIQR: 51.8 (17.2)<break/>13.2 (6.2)</td>
<td align="left">Healthy controls (68)</td>
<td align="left">Vitamin D, calcium, phosphorus</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Mader et al, 2012</bold> [<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">84</td>
<td align="left">Case-control</td>
<td align="left">52 (12)</td>
<td align="left">FIQ: 57.1 (20.2)</td>
<td align="left">Healthy controls (87)</td>
<td align="left">Ferritin, iron</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Maes et al, 2006</bold> [<xref ref-type="bibr" rid="pone.0176631.ref051">51</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">CFS</td>
<td align="left">12</td>
<td align="left">Case-control</td>
<td align="left">41.9 (13.2)</td>
<td align="left">NR</td>
<td align="left">Healthy controls (12)</td>
<td align="left">Zinc</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Study</bold></td>
<td align="left"><bold>Setting</bold></td>
<td align="left"><bold>Type of FSS</bold></td>
<td align="left"><bold>N of cases</bold></td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>Mean age in years (SD)</bold></td>
<td align="left"><bold>Mean FSS severity (SD) and/or mean duration in months (SD)</bold></td>
<td align="left"><bold>Comparison group (n)</bold></td>
<td align="left"><bold>Vitamin and/or mineral</bold></td>
<td align="left"><bold>Material</bold></td>
</tr>
<tr>
<td align="left"><bold>Mateos et al, 2014</bold> [<xref ref-type="bibr" rid="pone.0176631.ref052">52</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">205</td>
<td align="left">Case-control</td>
<td align="left">51.5 (9.6)</td>
<td align="left">NR</td>
<td align="left">Healthy controls (205)</td>
<td align="left">Vitamin D, calcium</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>McCully et al, 2005</bold> [<xref ref-type="bibr" rid="pone.0176631.ref053">53</xref>]</td>
<td align="left">NR</td>
<td align="left">CFS</td>
<td align="left">20</td>
<td align="left">Case-control</td>
<td align="left">NR</td>
<td align="left">NR</td>
<td align="left">Healthy sedentary controls (11)</td>
<td align="left">Magnesium</td>
<td align="left">Skeletal muscle</td>
</tr>
<tr>
<td align="left"><bold>Mechtouf et al, 1998</bold> [<xref ref-type="bibr" rid="pone.0176631.ref054">54</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">54</td>
<td align="left">Case-control</td>
<td align="left">Min-max: 20–75</td>
<td align="left">NR</td>
<td align="left">Healthy controls (36)</td>
<td align="left">Vitamin B1</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Miwa et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref055">55</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">CFS</td>
<td align="left">27</td>
<td align="left">Case-control</td>
<td align="left">29 (6)</td>
<td align="left">NR</td>
<td align="left">Secondary care patients free from fatigue for at least a month (27)</td>
<td align="left">Vitamin E</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Miwa et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref056">56</xref>]</td>
<td align="left">NR</td>
<td align="left">CFS</td>
<td align="left">50</td>
<td align="left">Case-control</td>
<td align="left">NR</td>
<td align="left">NR</td>
<td align="left">Healthy controls (40)</td>
<td align="left">Vitamin E</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Nazıroğlu et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref057">57</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">31</td>
<td align="left">RCT and case-control</td>
<td align="left">40.1 (5.2)</td>
<td align="left">Number tender points: 15 (2)</td>
<td align="left">Healthy controls (30)</td>
<td align="left">Vitamin A, C, E</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Ng et al, 1999</bold> [<xref ref-type="bibr" rid="pone.0176631.ref058">58</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">12</td>
<td align="left">Case-control</td>
<td align="left">44.6</td>
<td align="left">NR</td>
<td align="left">Healthy controls (12)</td>
<td align="left">Calcium, magnesium</td>
<td align="left">Hair</td>
</tr>
<tr>
<td align="left"><bold>Norregaard et al, 1994</bold> [<xref ref-type="bibr" rid="pone.0176631.ref059">59</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">15</td>
<td align="left">Case-control</td>
<td align="left">49</td>
<td align="left">NR</td>
<td align="left">Healthy controls (15)</td>
<td align="left">Potassium</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Okyay et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref060">60</xref>]</td>
<td align="left">Tertiary care</td>
<td align="left">FMS</td>
<td align="left">79</td>
<td align="left">Case-control</td>
<td align="left">37 (9)</td>
<td align="left">NR</td>
<td align="left">Healthy controls (80)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Olama et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref061">61</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">50</td>
<td align="left">Case-control</td>
<td align="left">32.3 (9.4)</td>
<td align="left">47 (24)</td>
<td align="left">Healthy controls (50)</td>
<td align="left">Vitamin D, calcium, phosphorus</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Ortancil et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">46</td>
<td align="left">Case-control</td>
<td align="left">46.9 (10.6)</td>
<td align="left">FIQ: 60.0 (10.9)</td>
<td align="left">Healthy controls (46)</td>
<td align="left">Vitamin B12, ferritin, folic acid</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Özcan et al, 2014</bold> [<xref ref-type="bibr" rid="pone.0176631.ref063">63</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">60</td>
<td align="left">Case-control</td>
<td align="left">41.9 (9.8)</td>
<td align="left">FIQ: 58.6 (10.3)<break/>27.3 (17.3)</td>
<td align="left">Healthy controls (30)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Study</bold></td>
<td align="left"><bold>Setting</bold></td>
<td align="left"><bold>Type of FSS</bold></td>
<td align="left"><bold>N of cases</bold></td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>Mean age in years (SD)</bold></td>
<td align="left"><bold>Mean FSS severity (SD) and/or mean duration in months (SD)</bold></td>
<td align="left"><bold>Comparison group (n)</bold></td>
<td align="left"><bold>Vitamin and/or mineral</bold></td>
<td align="left"><bold>Material</bold></td>
</tr>
<tr>
<td align="left"><bold>Reinhard et al, 1998</bold> [<xref ref-type="bibr" rid="pone.0176631.ref064">64</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">68</td>
<td align="left">Case-control</td>
<td align="left">47</td>
<td align="left">NR</td>
<td align="left">Blood donors without FM or musculoskeletal pain (97)</td>
<td align="left">Selenium</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Rezende Pena et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref065">65</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">87</td>
<td align="left">Case-control</td>
<td align="left">44.9 (8.6)</td>
<td align="left">Number tender points: 14 (5)</td>
<td align="left">Secondary care patients without FM or musculoskeletal pain (92)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">38</td>
<td align="left">Case-control</td>
<td align="left">Median (min-max): 49 (31–71)</td>
<td align="left">NR</td>
<td align="left">Healthy controls (41)</td>
<td align="left">Calcium, copper, ferritin, iodine, magnesium, molybdenum, potassium, selenium, sodium, zinc</td>
<td align="left">Whole blood, fasting urine</td>
</tr>
<tr>
<td align="left"><bold>Sakarya et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">40</td>
<td align="left">Case-control</td>
<td align="left">33.6 (7.6)</td>
<td align="left">FIQ: 61.3 (9.2)</td>
<td align="left">Healthy controls (40)</td>
<td align="left">Vitamin A, C, E, magnesium</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Samborski et al, 1997</bold> [<xref ref-type="bibr" rid="pone.0176631.ref068">68</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">60</td>
<td align="left">Case-control</td>
<td align="left">46,4 (9.8)</td>
<td align="left">NR</td>
<td align="left">Healthy controls (20)</td>
<td align="left">Calcium</td>
<td align="left">Plasma</td>
</tr>
<tr>
<td align="left"><bold>Sendur et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">32</td>
<td align="left">Case-control</td>
<td align="left">42.9 (7.7)</td>
<td align="left">FIQ: 53.3 (7.9)</td>
<td align="left">Healthy controls (32)</td>
<td align="left">Magnesium, selenium, zinc</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Tandeter et al, 2009</bold> [<xref ref-type="bibr" rid="pone.0176631.ref070">70</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">68</td>
<td align="left">Case-control</td>
<td align="left">43.8 (7.6)</td>
<td align="left">NR</td>
<td align="left">Regular periodic blood tests patients with no FM (82)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Türkyilmaz et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref071">71</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">FMS</td>
<td align="left">30</td>
<td align="left">Case-control</td>
<td align="left">39.8 (6.2)</td>
<td align="left">SF- 36: 47.4 (17.3)<break/>72 (62.2)</td>
<td align="left">Healthy controls (30)</td>
<td align="left">Vitamin D, calcium, phosphorus</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Ulusoy et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref072">72</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">30</td>
<td align="left">Case-control</td>
<td align="left">32.2 (6.8)</td>
<td align="left">FIQ: 64.7 (14.3)<break/>32.7 (19.7)</td>
<td align="left">Healthy controls (30)</td>
<td align="left">Vitamin D, calcium, phosphorus</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Study</bold></td>
<td align="left"><bold>Setting</bold></td>
<td align="left"><bold>Type of FSS</bold></td>
<td align="left"><bold>N of cases</bold></td>
<td align="left"><bold>Study design</bold></td>
<td align="left"><bold>Mean age in years (SD)</bold></td>
<td align="left"><bold>Mean FSS severity (SD) and/or mean duration in months (SD)</bold></td>
<td align="left"><bold>Comparison group (n)</bold></td>
<td align="left"><bold>Vitamin and/or mineral</bold></td>
<td align="left"><bold>Material</bold></td>
</tr>
<tr>
<td align="left"><bold>Vecchiet et al, 2002</bold> [<xref ref-type="bibr" rid="pone.0176631.ref073">73</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">CFS</td>
<td align="left">21</td>
<td align="left">Case-control</td>
<td align="left">42 (8)</td>
<td align="left">VAS muscle fatigue (0–100): 52.9 (4.9)<break/>44.5 (27.6)</td>
<td align="left">Healthy controls (20)</td>
<td align="left">Vitamin E</td>
<td align="left">Plasma, LDL</td>
</tr>
<tr>
<td align="left"><bold>Wepner et al, 2014</bold> [<xref ref-type="bibr" rid="pone.0176631.ref074">74</xref>]</td>
<td align="left">General population and secondary care</td>
<td align="left">FMS</td>
<td align="left">15</td>
<td align="left">RCT and cross-sectional</td>
<td align="left">Overall (n = 30) 48.3 (5.3)</td>
<td align="left">Number tender points: 15 (2)</td>
<td align="left">Placebo, FMS patients (15)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Witham et al, 2015</bold> [<xref ref-type="bibr" rid="pone.0176631.ref075">75</xref>]</td>
<td align="left">Secondary care</td>
<td align="left">CFS</td>
<td align="left">25</td>
<td align="left">RCT and case-control</td>
<td align="left">48.1 (12.0)</td>
<td align="left">Piper fatigue scale: 6.3 (1.6)</td>
<td align="left">Placebo, CFS patients (25)</td>
<td align="left"><italic>RCT</italic>: depending on serum levels 2400 or 1200 IU cholecalciferol<break/><italic>Observational</italic>: Vitamin D</td>
<td align="left">Serum</td>
</tr>
<tr>
<td align="left"><bold>Yildirim et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref076">76</xref>]</td>
<td align="left">NR</td>
<td align="left">FMS</td>
<td align="left">99</td>
<td align="left">Case-control</td>
<td align="left">49.4 (9.2)</td>
<td align="left">FIQ: 62.9 (17.7)</td>
<td align="left">Healthy controls (99)</td>
<td align="left">Vitamin D</td>
<td align="left">Serum</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>CFS = chronic fatigue syndrome, CIS = checklist individual strength (8–56), FIQ = fibromyalgia impact questionnaire (0–100), FIQR = revised fibromyalgia impact questionnaire (0–100), FMS = fibromyalgia syndrome, FSS = functional somatic syndrome, NR = not reported, RBC = red blood cells, RCT = randomised controlled trail, VAS = visual analogue scale.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0176631.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.t002</object-id>
<label>Table 2</label> <caption><title>Results of the quality assessment of observational studies.</title></caption>
<alternatives>
<graphic id="pone.0176631.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="left">Appro-priate selection of par-ticipants</th>
<th align="left">Validated disorder</th>
<th align="left">Repre-sentative controls</th>
<th align="left">In- and exclusion criteria</th>
<th align="left">Disease charac-teristics</th>
<th align="left">Appro-priate quanti-fication</th>
<th align="left">Validated methods</th>
<th align="left">Duplicate quanti-fication</th>
<th align="left">Appro-priate outcome</th>
<th align="left">Appro-priate control for con-founding</th>
<th align="left">Assessed con-founders</th>
<th align="left">Analyses adjusted</th>
<th align="left"><underline>Total score</underline></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Akkus et al, 2009 [<xref ref-type="bibr" rid="pone.0176631.ref032">32</xref>]</td>
<td align="left"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left"/>
<td align="left"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#808080"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Al-Allaf et al, 2003 [<xref ref-type="bibr" rid="pone.0176631.ref033">33</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Bagis et al, 2013 [<xref ref-type="bibr" rid="pone.0176631.ref034">34</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">7</td>
</tr>
<tr>
<td align="left">Baygutalp et al, 2014 [<xref ref-type="bibr" rid="pone.0176631.ref035">35</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">14</td>
</tr>
<tr>
<td align="left">Bazzichi et al, 2008 [<xref ref-type="bibr" rid="pone.0176631.ref036">36</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Costa et al, 2016 [<xref ref-type="bibr" rid="pone.0176631.ref038">38</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Eisinger et al, 1997 [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">Eisinger et al, 1996 [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">7</td>
</tr>
<tr>
<td align="left">Heidari et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref041">41</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">Jammes et al, 2011 [<xref ref-type="bibr" rid="pone.0176631.ref042">42</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Jammes et al, 2009 [<xref ref-type="bibr" rid="pone.0176631.ref043">43</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">11</td>
</tr>
<tr>
<td align="left">Kasapoğlu Aksoy et al, 2016 [<xref ref-type="bibr" rid="pone.0176631.ref044">44</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">Khalifa et al, 2016 [<xref ref-type="bibr" rid="pone.0176631.ref045">45</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Kim et al, 2011 [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Kurup et al, 2003 [<xref ref-type="bibr" rid="pone.0176631.ref047">47</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">La Rubia et al, 2013 [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Maafi et al, 2016 [<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>]</td>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">11</td>
</tr>
<tr>
<td align="left">Mader et al, 2012 [<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Maes et al, 2006 [<xref ref-type="bibr" rid="pone.0176631.ref051">51</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">Mateos et al, 2014 [<xref ref-type="bibr" rid="pone.0176631.ref052">52</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">7</td>
</tr>
<tr>
<td align="left">McCully et al, 2005 [<xref ref-type="bibr" rid="pone.0176631.ref053">53</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center">4</td>
</tr>
<tr>
<td align="left">Mechtouf et al, 1998 [<xref ref-type="bibr" rid="pone.0176631.ref054">54</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Miwa et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref055">55</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Miwa et al, 2008 [<xref ref-type="bibr" rid="pone.0176631.ref056">56</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Nazıroğlu et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref057">57</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Ng et al, 1999 [<xref ref-type="bibr" rid="pone.0176631.ref058">58</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Norregaard et al, 1994 [<xref ref-type="bibr" rid="pone.0176631.ref059">59</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">5</td>
</tr>
<tr>
<td align="left">Okyay et al, 2016 [<xref ref-type="bibr" rid="pone.0176631.ref060">60</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">Olama et al, 2013 [<xref ref-type="bibr" rid="pone.0176631.ref061">61</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">11</td>
</tr>
<tr>
<td align="left">Ortancil et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Özcan et al, 2014 [<xref ref-type="bibr" rid="pone.0176631.ref063">63</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Reinhard et al, 1998 [<xref ref-type="bibr" rid="pone.0176631.ref064">64</xref>]</td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center">7</td>
</tr>
<tr>
<td align="left">Rezende Pena et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref065">65</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">11</td>
</tr>
<tr>
<td align="left">Rosborg et al, 2007 [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">9</td>
</tr>
<tr>
<td align="left">Sakarya et al, 2011 [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Samborski et al, 1997 [<xref ref-type="bibr" rid="pone.0176631.ref068">68</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center">4</td>
</tr>
<tr>
<td align="left">Sendur et al, 2008 [<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Tandeter et al, 2009 [<xref ref-type="bibr" rid="pone.0176631.ref070">70</xref>]</td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">11</td>
</tr>
<tr>
<td align="left">Türkyilmaz et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref071">71</xref>]</td>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Ulusoy et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref071">71</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Vecchiet et al, 2002 [<xref ref-type="bibr" rid="pone.0176631.ref073">73</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Wepner et al, 2014 [<xref ref-type="bibr" rid="pone.0176631.ref074">74</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">10</td>
</tr>
<tr>
<td align="left">Witham et al, 2015 [<xref ref-type="bibr" rid="pone.0176631.ref075">75</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">14</td>
</tr>
<tr>
<td align="left">Yildirim et al, 2016 [<xref ref-type="bibr" rid="pone.0176631.ref076">76</xref>]</td>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="right" colspan="14">Total score mean (SD): 8.7 (2.2)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>According to the quality tool to assess methodological quality of vitamin and mineral studies in CFS and FM (<xref ref-type="supplementary-material" rid="pone.0176631.s003">S2 Appendix</xref>).</p></fn>
<fn id="t002fn002"><p>white = low risk, light gray = medium risk, dark gray = high risk</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="pone.0176631.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.t003</object-id>
<label>Table 3</label> <caption><title>Results of the quality assessment of randomized controlled trials.</title></caption>
<alternatives>
<graphic id="pone.0176631.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left"/>
<th align="left">Random sequence generation</th>
<th align="left">Allocation concealment</th>
<th align="left">Blinding of participants and personnel</th>
<th align="left">Blinding of outcome assessment</th>
<th align="left">Incomplete data</th>
<th align="left">Selective reporting quantification</th>
<th align="left">Other bias</th>
<th align="left"><underline>Total score</underline></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">Bagis et al, 2013 [<xref ref-type="bibr" rid="pone.0176631.ref034">34</xref>]</td>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#BFBFBF"/>
<td align="left" style="background-color:#808080"/>
<td align="left" style="background-color:#808080"/>
<td align="center">5</td>
</tr>
<tr>
<td align="left">Brouwers et al, 2002 [<xref ref-type="bibr" rid="pone.0176631.ref037">37</xref>]</td>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#808080"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Nazıroğlu et al, 2010 [<xref ref-type="bibr" rid="pone.0176631.ref057">57</xref>]</td>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">6</td>
</tr>
<tr>
<td align="left">Wepner et al, 2014 [<xref ref-type="bibr" rid="pone.0176631.ref074">74</xref>]</td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center" style="background-color:#808080"/>
<td align="center">8</td>
</tr>
<tr>
<td align="left">Witham et al, 2015 [<xref ref-type="bibr" rid="pone.0176631.ref075">75</xref>]</td>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center"/>
<td align="center" style="background-color:#BFBFBF"/>
<td align="center"/>
<td align="center" style="background-color:#808080"/>
<td align="center">12</td>
</tr>
<tr>
<td align="right" colspan="9">Total score mean (SD): 10.0 (2.6)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t003fn001"><p>According to the Cochrane Collaboration’s tool.</p></fn>
<fn id="t003fn002"><p>white = low risk, light gray = medium risk, dark gray = high risk</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Systematic review</title>
<p>Studies that were not included in the meta-analyses are presented in <xref ref-type="table" rid="pone.0176631.t004">Table 4</xref>.</p>
<table-wrap id="pone.0176631.t004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.t004</object-id>
<label>Table 4</label> <caption><title>Vitamin and mineral status in the included studies.</title></caption>
<alternatives>
<graphic id="pone.0176631.t004g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.t004" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<tbody>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><bold><underline>Vitamin A</underline></bold></td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Study</bold></td>
<td align="left" colspan="2"><underline><bold>Patients</bold></underline></td>
<td align="left" colspan="2"><underline><bold>Controls</bold></underline></td>
<td align="left" rowspan="2"><bold>Statistically significant</bold></td>
<td align="left" rowspan="2"><bold>Linked to clinical parameter</bold></td>
</tr>
<tr>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
</tr>
<tr>
<td align="left"><bold>Akkus et al, 2009</bold> [<xref ref-type="bibr" rid="pone.0176631.ref032">32</xref>]</td>
<td align="left">0.30 μmol/l</td>
<td align="left">0.10</td>
<td align="left">0.45</td>
<td align="left">0.16</td>
<td align="left">p&lt;.01</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Eisinger et al, 1997</bold> [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>]</td>
<td align="left">2.7 μmol/l</td>
<td align="left">1.5</td>
<td align="left">2.3</td>
<td align="left">0.9</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Nazıroğlu et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref057">57</xref>]</td>
<td align="left">1.5 μmol/l</td>
<td align="left">0.5</td>
<td align="left">2.4</td>
<td align="left">0.2</td>
<td align="left">p&lt;.05</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Sakarya et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>]</td>
<td align="left">1.46 mmol/l</td>
<td align="left">0.47</td>
<td align="left">1.25</td>
<td align="left">0.26</td>
<td align="left">NS</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: -0.083 (NS)</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><bold><underline>Vitamin B1</underline></bold></td>
</tr>
<tr>
<td align="left"><bold>Mechtouf et al, 1998</bold> [<xref ref-type="bibr" rid="pone.0176631.ref054">54</xref>]</td>
<td align="left">58 ng/ml</td>
<td align="left">38.9</td>
<td align="left">49.6</td>
<td align="left">14.8</td>
<td align="left">p&lt;.05</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><bold><underline>Vitamin B12</underline></bold></td>
</tr>
<tr>
<td align="left"><bold>Ortancil et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>]</td>
<td align="left">297.6 pg/ml</td>
<td align="left">120.7</td>
<td align="left">295.7</td>
<td align="left">113.0</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><bold><underline>Vitamin C</underline></bold></td>
</tr>
<tr>
<td align="left"><bold>Sakarya et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: -0.115 (NS)</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><bold><underline>Vitamin D</underline></bold></td>
</tr>
<tr>
<td align="left"><bold>Al-Allaf et al, 2003</bold> [<xref ref-type="bibr" rid="pone.0176631.ref033">33</xref>]</td>
<td align="left">&lt;20nmol/l (n (%)):</td>
<td align="left">18 (45)</td>
<td align="left">n (%):</td>
<td align="left">7 (18.9%)</td>
<td align="left">p&lt;0.015</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Baygutalp et al, 2014</bold> [<xref ref-type="bibr" rid="pone.0176631.ref035">35</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Spearman correlation</italic>: 0.231 (NS)</td>
</tr>
<tr>
<td align="left"><bold>Kasapoğlu Aksoy et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref044">44</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><italic>&lt;30 ng/ml vs &gt;30 ng/ml in FMS</italic>:<break/><underline><italic>VAS pain</italic></underline>: 8.4 (1.6) <italic>vs</italic> 6.7 (2.0) p = .002<break/><underline><italic>FIQ</italic></underline>: 65.4 (12.0) <italic>vs</italic> 57.2 (16.1) p = .088</td>
</tr>
<tr>
<td align="left"><bold>Maafi et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>FIQR</italic></underline> <italic>Spearman correlation</italic>: -0.093 (NS)<break/><underline><italic>Number of tender points</italic></underline>: -0.194 (NS)<break/><underline><italic>VAS pain</italic></underline>: -0.097 (NS)</td>
</tr>
<tr>
<td align="left"><bold>Okyay et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref060">60</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><italic>&lt;20 ngl/ml vs 20–30 vs &gt;30 ng/ml in FMS</italic>:<break/><underline><italic>FIQ</italic></underline>: 56.6 (8.9) <italic>vs</italic> 48.8 (2.8) <italic>vs</italic> 41.4 (8.2) p = .000<break/><underline><italic>VAS pain</italic></underline>: 7.4 (1.4) <italic>vs</italic> 6.4 (0.5) <italic>vs</italic> 5.1 (1.0) p = .000<break/><underline><italic>FIQ</italic></underline> <italic>Spearman correlation</italic>: -0.621 (p = .000)<break/><underline><italic>VAS pain</italic></underline> <italic>Spearman correlation</italic>: -0.578 (p = .000)</td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Study</bold></td>
<td align="left" colspan="2"><underline><bold>Patients</bold></underline></td>
<td align="left" colspan="2"><underline><bold>Controls</bold></underline></td>
<td align="left" rowspan="2"><bold>Statistically significant</bold></td>
<td align="left" rowspan="2"><bold>Linked to clinical parameter</bold></td>
</tr>
<tr>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
</tr>
<tr>
<td align="left"><bold>Rezende Pena et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref065">65</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>Number of tender points</italic></underline> <italic>Pearson’s correlation coefficient</italic>: -0.160 (NS)<break/><underline><italic>VAS pain</italic></underline>: -0.196 (NS)</td>
</tr>
<tr>
<td align="left"><bold>Ulusoy et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref072">72</xref>]</td>
<td align="left">&lt;20ng/l (n (%)):</td>
<td align="left">26 (86.7)</td>
<td align="left">n (%):</td>
<td align="left">29 (96.7)</td>
<td align="left">NS</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: 0.071 (NS)</td>
</tr>
<tr>
<td align="left"><bold>Wepner et al, 2014</bold> [<xref ref-type="bibr" rid="pone.0176631.ref074">74</xref>]</td>
<td align="left">19.94 ng/ml</td>
<td align="left">6.066</td>
<td align="left">NR</td>
<td align="left">NR</td>
<td align="left">NR</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Witham et al, 2015</bold> [<xref ref-type="bibr" rid="pone.0176631.ref075">75</xref>]</td>
<td align="left">44 and 48 nmol/l</td>
<td align="left">15 and 20</td>
<td align="left">NR</td>
<td align="left">NR</td>
<td align="left">NR</td>
<td align="left"><underline><italic>Piper fatigue scale</italic></underline>: no improvement after vitamin D3 treatment</td>
</tr>
<tr>
<td align="left"><bold>Yildirim et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref076">76</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: r = 0.112 (NS)<break/><underline><italic>VAS pain</italic></underline>: r = 0.104 (NS)</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Vitamin E</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Kurup et al, 2003</bold> [<xref ref-type="bibr" rid="pone.0176631.ref047">47</xref>]</td>
<td align="left">5.22 μg/ml RBC</td>
<td align="left">0.31</td>
<td align="left">5.25</td>
<td align="left">0.33</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Miwa et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref055">55</xref>]</td>
<td align="left">2.81 mg/g lipids</td>
<td align="left">0.73</td>
<td align="left">3.88</td>
<td align="left">0.65</td>
<td align="left">p&lt;.001</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Miwa et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref056">56</xref>]</td>
<td align="left">3.03 mg/g lipids</td>
<td align="left">0.72</td>
<td align="left">3.78</td>
<td align="left">0.66</td>
<td align="left">p&lt;.001</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Sakarya et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: −0.171 (NS)</td>
</tr>
<tr>
<td align="left"><bold>Vecchiet et al, 2002</bold> [<xref ref-type="bibr" rid="pone.0176631.ref073">73</xref>]</td>
<td align="left">9.5 μmol/mg LDL</td>
<td align="left">1.0</td>
<td align="left">18.0</td>
<td align="left">1.5</td>
<td align="left">p&lt;.001</td>
<td align="left"><italic>Linear regression analyses</italic> <underline><italic>fatigue</italic></underline> <italic>versus vitamin E in plasma</italic>:<break/>Y = 56.674–0.4467X<break/>r = -0.6098 (p &lt; 0.004)</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Calcium</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Bazzichi et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref036">36</xref>]</td>
<td align="left">231.0 nM platelet</td>
<td align="left">13.75 (SEM)</td>
<td align="left">198.3</td>
<td align="left">10.40</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">775 μg/g</td>
<td align="left">439–1,366 (95%CI)</td>
<td align="left">1,093</td>
<td align="left">591–2,020</td>
<td align="left">p = .001</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Ng et al, 1999</bold> [<xref ref-type="bibr" rid="pone.0176631.ref058">58</xref>]</td>
<td align="left">2288.4 μg/g hair</td>
<td align="left">1486.2</td>
<td align="left">846.3</td>
<td align="left">645.7</td>
<td align="left">p = .025</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">49 mg/l (median whole blood)<break/>72.8 mg/l (median urine)</td>
<td align="left">28.5–62.2<break/>&lt;29–258<break/>(range)</td>
<td align="left">48.0<break/>74.5</td>
<td align="left">39.7–58.5<break/>&lt;29–519</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Copper</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Khalifa et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref045">45</xref>]</td>
<td align="left">145.8 μg/dl</td>
<td align="left">17.34</td>
<td align="left">116.50</td>
<td align="left">14.35</td>
<td align="left">p&lt;.05</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">28.3 μg/g</td>
<td align="left">11.8–68.1<break/> (95%CI)</td>
<td align="left">40.2</td>
<td align="left">16.1–100.0</td>
<td align="left">p = .029</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>La Rubia et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>]</td>
<td align="left">105.99 mg/dl</td>
<td align="left">17.03</td>
<td align="left">83.55</td>
<td align="left">9.20</td>
<td align="left">p&lt;.001</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Study</bold></td>
<td align="left" colspan="2"><underline><bold>Patients</bold></underline></td>
<td align="left" colspan="2"><underline><bold>Controls</bold></underline></td>
<td align="left" rowspan="2"><bold>Statistically significant</bold></td>
<td align="left" rowspan="2"><bold>Linked to clinical parameter</bold></td>
</tr>
<tr>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">971 μg/l (median whole blood)<break/>28.1 μg/l (median urine)</td>
<td align="left">620–1740<break/>6.7–186<break/>(range)</td>
<td align="left">855<break/>34.7</td>
<td align="left">690–1475<break/>8.6–92.2</td>
<td align="left">p = .002<break/>NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Ferritin</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">5.90 μg/g</td>
<td align="left">4.21–8.26<break/> (95%CI)</td>
<td align="left">7.10</td>
<td align="left">4.73–10.66</td>
<td align="left">p = .007</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>La Rubia et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>]</td>
<td align="left">52.33 g/dl</td>
<td align="left">15.07</td>
<td align="left">57.42</td>
<td align="left">17.01</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Mader et al, 2012</bold> [<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>]</td>
<td align="left">63.68 ng/ml<break/>≤30 ng/mL n (%):<break/> 23 (27.4)</td>
<td align="left">49.72</td>
<td align="left">53.70<break/>n (%): 38 (43.7)</td>
<td align="left">46.24</td>
<td align="left">p = .18<break/>p&lt;.04</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Spearman correlation</italic>: NS</td>
</tr>
<tr>
<td align="left"><bold>Ortancil et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>]</td>
<td align="left">27.3 ng/ml<break/>&lt;50 ng/mL n (%):<break/> 40 (87.0)</td>
<td align="left">20.9</td>
<td align="left">43.8<break/>n (%): 26 (56.5)</td>
<td align="left">30.8</td>
<td align="left">p = .035<break/>p = .001</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Spearman correlation</italic>: NS</td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">422 mg/l (median)</td>
<td align="left">245–585 (range)</td>
<td align="left">400</td>
<td align="left">273–465</td>
<td align="left">p = .046</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Folic acid</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Ortancil et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>]</td>
<td align="left">9.2 ng/ml</td>
<td align="left">3.1</td>
<td align="left">8.9</td>
<td align="left">2.5</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Iodine</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">&lt;650 μg/l (median whole blood)<break/>788 μg/l (median urine)</td>
<td align="left">&lt;650–1900<break/>&lt;130–5395<break/>(range)</td>
<td align="left">&lt;650<break/>2000</td>
<td align="left">&lt;650–693<break/>&lt;130–12145</td>
<td align="left">NS<break/>p = .001</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Iron</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>La Rubia et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>]</td>
<td align="left">81.82 mg/dl</td>
<td align="left">34.64</td>
<td align="left">83</td>
<td align="left">30.07</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Mader et al, 2012</bold> [<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>]</td>
<td align="left">82.32 μg/dl</td>
<td align="left">32.75</td>
<td align="left">75.31</td>
<td align="left">29.13</td>
<td align="left">NS</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Spearman correlation</italic>: NS</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Magnesium</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Bagis et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref034">34</xref>]</td>
<td align="left">Erythrocyte:<break/> 2.27/2.70/2.91 mmol/l</td>
<td align="left">0.41/0.47/0.42</td>
<td align="left">3.22 mmol/l</td>
<td align="left">0.36</td>
<td align="left">p&lt;.001</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation serum Mg</italic>:<break/> -0.426 (p&lt;.001)<break/><italic>Erythrocyte Mg</italic>:<break/> -0.309 (p = .013)</td>
</tr>
<tr>
<td align="left"><bold>Bazzichi et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref036">36</xref>]</td>
<td align="left">1.30 mM platelet</td>
<td align="left">0.079 (SEM)</td>
<td align="left">1.07</td>
<td align="left">0.056</td>
<td align="left">p = .02</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Eisinger et al, 1997</bold> [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>]</td>
<td align="left">2.36 mmol/l erythrocyte</td>
<td align="left">0.24</td>
<td align="left">2.39</td>
<td align="left">0.24</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Eisinger et al, 1996</bold> [<xref ref-type="bibr" rid="pone.0176631.ref040">40</xref>]</td>
<td align="left">4.9 fmol/cell lencocyte</td>
<td align="left">1.7</td>
<td align="left">3.9</td>
<td align="left">1.3</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">52 μg/g</td>
<td align="left">25–107 (95%CI)</td>
<td align="left">72</td>
<td align="left">36–147</td>
<td align="left">p = .008</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Study</bold></td>
<td align="left" colspan="2"><underline><bold>Patients</bold></underline></td>
<td align="left" colspan="2"><underline><bold>Controls</bold></underline></td>
<td align="left" rowspan="2"><bold>Statistically significant</bold></td>
<td align="left" rowspan="2"><bold>Linked to clinical parameter</bold></td>
</tr>
<tr>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
</tr>
<tr>
<td align="left"><bold>McCully et al, 2005</bold> [<xref ref-type="bibr" rid="pone.0176631.ref053">53</xref>]</td>
<td align="left">0.47 mM muscle</td>
<td align="left">0.07</td>
<td align="left">0.36</td>
<td align="left">0.06</td>
<td align="left">p&lt;.01</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Ng et al, 1999</bold> [<xref ref-type="bibr" rid="pone.0176631.ref058">58</xref>]</td>
<td align="left">84.7 μg/g hair</td>
<td align="left">73.3</td>
<td align="left">46.8</td>
<td align="left">28.9</td>
<td align="left">p = .05</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">28.6 mg/l (median whole blood)<break/>47.1 mg/l (median urine)</td>
<td align="left">24.5–37.8<break/>&lt;25–189 (range)</td>
<td align="left">28.2<break/>60.5</td>
<td align="left">23.2–37.2<break/>&lt;25–171</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Sakarya et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: 0.014 (NS)</td>
</tr>
<tr>
<td align="left"><bold>Sendur et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>]</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left">x</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: -0.040 (NS)</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Manganese</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">140 ng/g</td>
<td align="left">80–260 (95%CI)</td>
<td align="left">190</td>
<td align="left">80–480</td>
<td align="left">p = .029</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Molybdenum</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">0.6 μg/l (median)</td>
<td align="left">&lt;0.25–4.4 (range)</td>
<td align="left">0.6</td>
<td align="left">&lt;0.25–5.7</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Phosphorus</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">146 μg/g</td>
<td align="left">116–183 (95%CI)</td>
<td align="left">143</td>
<td align="left">116–176</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Maafi et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>]</td>
<td align="left">3.6 mg/dl</td>
<td align="left">0.47</td>
<td align="left">3.66</td>
<td align="left">0.54</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Olama et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref061">61</xref>]</td>
<td align="left">3.55 mg/dl</td>
<td align="left">0.12</td>
<td align="left">3.6</td>
<td align="left">0.16</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Türkyilmaz et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref071">71</xref>]</td>
<td align="left">3.2 mg/dl</td>
<td align="left">0.4</td>
<td align="left">3.3</td>
<td align="left">0.5</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Ulusoy et al, 2010</bold> [<xref ref-type="bibr" rid="pone.0176631.ref072">72</xref>]</td>
<td align="left">3.54 mg/dl</td>
<td align="left">0.56</td>
<td align="left">3.57</td>
<td align="left">0.46</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Polynutrient supplement</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Brouwers et al, 2002</bold> [<xref ref-type="bibr" rid="pone.0176631.ref037">37</xref>]</td>
<td align="left">Baseline CIS: 51.4<break/>Follow up CIS: 48.6</td>
<td align="left">4.2<break/>7.4</td>
<td align="left">51.3<break/>48.2</td>
<td align="left">3.6<break/>7.6</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Potassium</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Jammes et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref042">42</xref>]</td>
<td align="left">3.92 mmol/l</td>
<td align="left">0.12</td>
<td align="left">3.99</td>
<td align="left">0.08</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">75 μg/g</td>
<td align="left">25–219 (95%CI)</td>
<td align="left">56</td>
<td align="left">23–138</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Norregaard et al, 1994</bold> [<xref ref-type="bibr" rid="pone.0176631.ref059">59</xref>]</td>
<td align="left">3.25 mmol/l (median)</td>
<td align="left">NR</td>
<td align="left">3.9</td>
<td align="left">NR</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">926 mg/l (median urine)</td>
<td align="left">205–3300 (range)</td>
<td align="left">1410</td>
<td align="left">378–5200</td>
<td align="left">p = .013</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Selenium</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Eisinger et al, 1997</bold> [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>]</td>
<td align="left">83 ng/ml</td>
<td align="left">17</td>
<td align="left">87</td>
<td align="left">12</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">75 μg/g</td>
<td align="left">25–219 (95%CI)</td>
<td align="left">56</td>
<td align="left">23–138</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Reinhard et al, 1998</bold> [<xref ref-type="bibr" rid="pone.0176631.ref064">64</xref>]</td>
<td align="left">Median: 70.8 μg/l</td>
<td align="left">67.7–75.3 (95%CI)</td>
<td align="left">76.8</td>
<td align="left">73.4–81.6</td>
<td align="left">p&lt;.05</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" rowspan="2"><bold>Study</bold></td>
<td align="left" colspan="2"><underline><bold>Patients</bold></underline></td>
<td align="left" colspan="2"><underline><bold>Controls</bold></underline></td>
<td align="left" rowspan="2"><bold>Statistically significant</bold></td>
<td align="left" rowspan="2"><bold>Linked to clinical parameter</bold></td>
</tr>
<tr>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
<td align="left"><bold>Mean</bold></td>
<td align="left"><bold>SD</bold></td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">117 μg/l (median whole blood)<break/>18.4 μg/l (median urine)</td>
<td align="left">77.6–207<break/>5.5–55.7 (range)</td>
<td align="left">105<break/>23.5</td>
<td align="left">66.4–137<break/>2.3–52.2</td>
<td align="left">p = .015<break/>NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Sendur et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>]</td>
<td align="left">44.4 μg/dl</td>
<td align="left">12.1</td>
<td align="left">38.7</td>
<td align="left">13.9</td>
<td align="left">NS</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: 0.011 (NS)</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Sodium</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Jammes et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref042">42</xref>]</td>
<td align="left">138 mmol/l</td>
<td align="left">0.5</td>
<td align="left">140</td>
<td align="left">0.4</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">78 μg/g</td>
<td align="left">31–195 (95%CI)</td>
<td align="left">72</td>
<td align="left">27–195</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">1560 mg/l (median urine)</td>
<td align="left">90.8–3705 (range)</td>
<td align="left">1700</td>
<td align="left">510–4790</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left" colspan="7" style="background-color:#D9D9D9"><underline><bold>Zinc</bold></underline></td>
</tr>
<tr>
<td align="left"><bold>Eisinger et al, 1997</bold> [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>]</td>
<td align="left">16.9 mmol/l</td>
<td align="left">1.8</td>
<td align="left">16.1</td>
<td align="left">1.9</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Khalifa et al, 2016</bold> [<xref ref-type="bibr" rid="pone.0176631.ref045">45</xref>]</td>
<td align="left">75.87 μg/dL</td>
<td align="left">5.5</td>
<td align="left">93.21</td>
<td align="left">11.94</td>
<td align="left">p&lt;.05</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Kim et al, 2011</bold> [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>]</td>
<td align="left">167 μg/g</td>
<td align="left">120–232 (95%CI)</td>
<td align="left">165</td>
<td align="left">125–217</td>
<td align="left">NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>La Rubia et al, 2013</bold> [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>]</td>
<td align="left">66.48 ng/ml</td>
<td align="left">18.82</td>
<td align="left">106.8</td>
<td align="left">22.41</td>
<td align="left">p&lt;.001</td>
<td align="left"><underline><italic>PCS-12</italic></underline> <italic>Pearson’s correlation coefficient</italic>: 0.402 (p = .017)</td>
</tr>
<tr>
<td align="left"><bold>Maes et al, 2006</bold> [<xref ref-type="bibr" rid="pone.0176631.ref051">51</xref>]</td>
<td align="left">73.5 mg/dl</td>
<td align="left">NR</td>
<td align="left">87</td>
<td align="left">NR</td>
<td align="left">p = .0001</td>
<td align="left"><underline><italic>Fibrofatigue scale</italic></underline> <italic>Pearson’s correlation coefficient</italic>: -0.039 (NS)</td>
</tr>
<tr>
<td align="left"><bold>Rosborg et al, 2007</bold> [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>]</td>
<td align="left">6000 μg/l (median whole blood)<break/>294 μg/l (median urine)</td>
<td align="left">3720–9400<break/>35.8–1230<break/>(range)</td>
<td align="left">5450<break/>290</td>
<td align="left">3900–7300<break/>35.0–66.5</td>
<td align="left">p = .026<break/>NS</td>
<td align="left">NR</td>
</tr>
<tr>
<td align="left"><bold>Sendur et al, 2008</bold> [<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>]</td>
<td align="left">102.8 μg/dl</td>
<td align="left">24.7</td>
<td align="left">77.2</td>
<td align="left">31</td>
<td align="left">p = .001</td>
<td align="left"><underline><italic>FIQ</italic></underline> <italic>Pearson’s correlation coefficient</italic>: -0.106 (NS)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t004fn001"><p>CI = confidence interval, CIS = checklist individual strength, FIQ = fibromyalgia impact questionnaire, FIQR = revised fibromyalgia impact questionnaire, NR = not reported, NS = not significant, PCS = physical component summary, SD = standard deviation, VAS = visual analogue scale, x = reported in meta-analyses.</p></fn>
</table-wrap-foot>
</table-wrap>
<sec id="sec016">
<title>Interventions</title>
<p>Five RCTs were included. The first RCT determined the effect of magnesium citrate treatment in combination with amitriptyline versus amitriptyline only, on FMS symptoms, over a period of 8 weeks [<xref ref-type="bibr" rid="pone.0176631.ref034">34</xref>]. They found that amitriptyline and magnesium supplementation was more effective on all measured outcomes than amitriptyline alone. The second RCT investigated the effect of a polynutrient supplement (containing several vitamins (including A, B, C, D, E), minerals (including calcium, magnesium) and (co)enzymes), on fatigue and physical activity of patients with CFS, over a period of 10 weeks [<xref ref-type="bibr" rid="pone.0176631.ref037">37</xref>]. They found no significant difference between the placebo and treatment group on any of the outcome measures. A third RCT examined vitamin C and E treatment combined with exercise versus exercise only, in FMS patients, over a period of 12 weeks [<xref ref-type="bibr" rid="pone.0176631.ref057">57</xref>]. Although both interventions lead to significantly higher vitamin A, C, and E serum levels, the FMS symptoms did not improve in both groups. Furthermore, the most recent RCT investigated the effect of vitamin D, on symptoms in CFS patients, over a period of 6 months [<xref ref-type="bibr" rid="pone.0176631.ref075">75</xref>]. Despite a statistically significant increase in vitamin D, they found no evidence of improvement in symptoms of fatigue or depression. Lastly, in the fifth RCT, cholecalciferol was administered for 20 weeks in FMS patients, with the dosage depending on patients calcifediol levels [<xref ref-type="bibr" rid="pone.0176631.ref074">74</xref>]. A significant treatment effect on intensity of pain was found in the treatment group versus placebo. No changes in somatization, depression and anxiety, physical and mental health, and FMS symptom severity were observed in both the treatment and placebo group.</p>
</sec>
<sec id="sec017">
<title>Clinical parameters</title>
<p>All studies investigating vitamin A (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>], vitamin C (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>], ferritin (n = 2) [<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>,<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>], iron (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>], and selenium (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>], found no significant associations between vitamin and mineral status and clinical parameters in FMS patients (<xref ref-type="table" rid="pone.0176631.t003">Table 3</xref>). Most studies investigating vitamin D (n = 6) found no significant associations between vitamin D and clinical parameters in CFS [<xref ref-type="bibr" rid="pone.0176631.ref075">75</xref>] and FMS [<xref ref-type="bibr" rid="pone.0176631.ref035">35</xref>,<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>,<xref ref-type="bibr" rid="pone.0176631.ref065">65</xref>,<xref ref-type="bibr" rid="pone.0176631.ref072">72</xref>,<xref ref-type="bibr" rid="pone.0176631.ref076">76</xref>] patients. However, two studies found significantly higher VAS-score for pain in patients with vitamin D levels &lt;30 ng/ml compared to FMS patients with vitamin D levels of &gt;30ng/ml [<xref ref-type="bibr" rid="pone.0176631.ref044">44</xref>,<xref ref-type="bibr" rid="pone.0176631.ref060">60</xref>]. Significant negative associations were found for vitamin E in plasma and fatigue in CFS patients (n = 1/2) [<xref ref-type="bibr" rid="pone.0176631.ref073">73</xref>], and serum and erythrocyte magnesium and fibromyalgia symptoms (n = 1/3) [<xref ref-type="bibr" rid="pone.0176631.ref034">34</xref>]. A significant positive association was found for serum zinc and somatic symptoms in fibromyalgia patients (n = 1/3) [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>].</p>
</sec>
<sec id="sec018">
<title>Vitamin and mineral status</title>
<p>All studies that investigated vitamin B12 (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>], folic acid (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>], iron (n = 2) [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>,<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>], molybdenum (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>], phosphorus (n = 4) [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>,<xref ref-type="bibr" rid="pone.0176631.ref061">61</xref>,<xref ref-type="bibr" rid="pone.0176631.ref071">71</xref>,<xref ref-type="bibr" rid="pone.0176631.ref072">72</xref>] sodium (n = 3) [<xref ref-type="bibr" rid="pone.0176631.ref042">42</xref>,<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>], and iodine (n = 1) [<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>], and the majority of studies that investigated potassium (n = 3/4) [<xref ref-type="bibr" rid="pone.0176631.ref042">42</xref>,<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0176631.ref059">59</xref>], and selenium status (n = 4/5) [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>,<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>,<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>] found no statistically significant difference between patients and controls (<xref ref-type="table" rid="pone.0176631.t003">Table 3</xref>). In contrast, all studies that investigated vitamin B1 (n = 1/1) [<xref ref-type="bibr" rid="pone.0176631.ref054">54</xref>], and manganese (n = 1/1) [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>], and the majority of studies that investigated vitamin A (n = 2/4) [<xref ref-type="bibr" rid="pone.0176631.ref039">39</xref>,<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>], found statistically significant lower serum values in patients versus controls. The majority of the studies that were not suitable for inclusion in the meta-analyses reported significantly lower vitamin E in patients versus controls (n = 3/4) [<xref ref-type="bibr" rid="pone.0176631.ref055">55</xref>,<xref ref-type="bibr" rid="pone.0176631.ref056">56</xref>,<xref ref-type="bibr" rid="pone.0176631.ref073">73</xref>]. Statistically significant results were found in the majority of the included studies investigating copper (n = 3/4) [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>,<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>], ferritin (n = 4/5) [<xref ref-type="bibr" rid="pone.0176631.ref046">46</xref>,<xref ref-type="bibr" rid="pone.0176631.ref050">50</xref>,<xref ref-type="bibr" rid="pone.0176631.ref062">62</xref>,<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>], and zinc (n = 5/7) status [<xref ref-type="bibr" rid="pone.0176631.ref048">48</xref>,<xref ref-type="bibr" rid="pone.0176631.ref051">51</xref>,<xref ref-type="bibr" rid="pone.0176631.ref066">66</xref>,<xref ref-type="bibr" rid="pone.0176631.ref069">69</xref>]. However, the direction of the differences was equivocal for all three minerals: levels of copper were higher among patients in 3 studies and lower in 1, levels ferritin were higher among patients in 2 studies and lower in 2, and levels of zinc were lower in 3 studies and higher in 2.</p>
</sec>
</sec>
<sec id="sec019">
<title>Meta-analysis</title>
<p>Vitamin C, vitamin D, vitamin D deficiency (&lt;20ng/ml), vitamin E (<xref ref-type="fig" rid="pone.0176631.g002">Fig 2</xref>), and the minerals calcium, and magnesium status, and were reported in more than five studies and were therefore investigated using meta-analysis (<xref ref-type="fig" rid="pone.0176631.g003">Fig 3</xref>). Meta-analysis revealed that circulating concentrations of vitamin E were lower in patients compared to controls (patients n = 162, controls n = 140; pooled SMD:-1.57, 95%CI:-3.09,-0.05; p = .042). No differences were found in patients compared to controls in circulating concentrations of vitamin C (patients n = 124, controls n = 132; pooled SMD:-0.55, 95%CI:-1.38,0.28; p = .19), vitamin D (patients n = 871, controls n = 1039; pooled SMD:-0.17, 95%CI:-0.41,0.06; p = .15), and vitamin D deficiency (patients n = 435, controls n = 604; pooled OR:0.23, 95%CI:-0.54,0.99; p = .17). There were no differences between patients and controls in circulating concentrations of the minerals calcium (patients n = 620, controls n = 518; pooled SMD:-0.15, 95%CI:-0.50,0.19; p = .38), and magnesium (patients n = 218, controls n = 148; pooled SMD:-0.59, 95%CI:-1.33,0.15; p = .12). All analyses revealed substantial to considerable heterogeneity in the effect sizes, as can be found in <xref ref-type="fig" rid="pone.0176631.g002">Fig 2</xref>.</p>
<fig id="pone.0176631.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Forest plots of studies investigating vitamins.</title>
<p>(A) Vitamin C; (B) Vitamin D; (C) Vitamin D deficiency (&lt;20ng/ml); (D) Vitamin E.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.g002" xlink:type="simple"/>
</fig>
<fig id="pone.0176631.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plots of studies investigating minerals.</title>
<p>(A) Calcium; (B) Magnesium.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.g003" xlink:type="simple"/>
</fig>
<sec id="sec020">
<title>Subgroup analyses</title>
<p>Subgroup analyses were performed including studies with more than half the maximum study quality score (&gt;9 quality points), if more than three studies with a sufficient quality score were available. The additional analysis was not possible for magnesium, since only two studies achieved more than half of the maximum quality score. No differences in circulating concentrations of vitamin C (patients n = 93, controls n = 102, pooled SMD:-0.78, 95CI:-1.95, 0.39; p = .19) [<xref ref-type="bibr" rid="pone.0176631.ref032">32</xref>,<xref ref-type="bibr" rid="pone.0176631.ref042">42</xref>,<xref ref-type="bibr" rid="pone.0176631.ref043">43</xref>,<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>], vitamin D (patients n = 358, controls n = 376, pooled SMD:-0.07, 95%CI:-0.44,0.30; p = .71) [<xref ref-type="bibr" rid="pone.0176631.ref035">35</xref>,<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>,<xref ref-type="bibr" rid="pone.0176631.ref061">61</xref>,<xref ref-type="bibr" rid="pone.0176631.ref065">65</xref>,<xref ref-type="bibr" rid="pone.0176631.ref070">70</xref>–<xref ref-type="bibr" rid="pone.0176631.ref072">72</xref>], vitamin D deficiency (patients n = 121, controls n = 130; pooled OR:-0.12, 95%CI:-1.24,1.01; p = .84) [<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>,<xref ref-type="bibr" rid="pone.0176631.ref061">61</xref>,<xref ref-type="bibr" rid="pone.0176631.ref065">65</xref>,<xref ref-type="bibr" rid="pone.0176631.ref070">70</xref>], and calcium = (patients n = 184, controls n = 178; pooled SMD:0.18 95%CI:-0.18,0.54; p = .34) [<xref ref-type="bibr" rid="pone.0176631.ref049">49</xref>,<xref ref-type="bibr" rid="pone.0176631.ref061">61</xref>,<xref ref-type="bibr" rid="pone.0176631.ref071">71</xref>,<xref ref-type="bibr" rid="pone.0176631.ref072">72</xref>] were found. The significant difference in circulating concentrations of vitamin E between patients and controls disappeared when studies with low quality score were excluded (patients n = 91, controls n = 90, pooled SMD: -1.86, 95%CI:-4.28, 0.56; p = .13) [<xref ref-type="bibr" rid="pone.0176631.ref032">32</xref>,<xref ref-type="bibr" rid="pone.0176631.ref067">67</xref>,<xref ref-type="bibr" rid="pone.0176631.ref073">73</xref>].</p>
<p>Subgroup analyses were performed separately for the syndromes, when more than three studies were available per syndrome. Since vitamin D, vitamin D deficiency and calcium were only determined in FMS patients, additional subgroup analyses were possible for vitamin C, vitamin E and magnesium. No statistically significant difference between patients and controls was found in the three studies investigating circulating concentrations of vitamin C in FMS patients (patients n = 101, controls n = 100; pooled SMD:0.14, 95%CI:-0.16,0.44; p = .32). However, the heterogeneity was substantially lower (I<sup>2</sup> = 13.3% versus 88.5% in the overall analysis including CFS patients), indicating a high consistency of studies’ results. The significant difference in circulating concentrations of vitamin E between patients and controls disappeared when the single CFS study was excluded (patients n = 141, controls n = 120; pooled SMD:-0.95, 95%CI:-2.41,0.50; p = .20. Lastly, no considerable differences were found in analyses of the five studies investigating circulating concentrations of magnesium in FMS patients (patients n = 203, controls n = 133; pooled SMD:-0.51, 95%CI:-1.34,0.32; p = .23).</p>
</sec>
<sec id="sec021">
<title>Publication bias</title>
<p>Finally, we tested whether publication bias could have affected the results. Corresponding funnel plots can be found in <xref ref-type="fig" rid="pone.0176631.g004">Fig 4</xref>. Egger's test showed that there was significant funnel plot asymmetry in vitamin E (p = .039), with no significant asymmetry among the other analyses. Trimming was performed in the calcium studies using the Trim and Fill test, and the contour-enhanced funnel plot revealed two added studies in the statistically significant areas. No studies were trimmed or filled among the vitamin C, vitamin D, vitamin D deficiency, vitamin E, and magnesium studies, indicating absence of substantial publication bias.</p>
<fig id="pone.0176631.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0176631.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Funnel plots.</title>
<p>(A) Vitamin C; (B) Vitamin D; (C) Vitamin D deficiency (&lt;20ng/ml); (D) Vitamin E; (E) Calcium; (F) Magnesium.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.g004" xlink:type="simple"/>
</fig>
</sec>
</sec>
</sec>
<sec id="sec022" sec-type="conclusions">
<title>Discussion</title>
<p>We found little evidence to support our hypothesis that vitamin and mineral deficiencies play a role in the pathophysiology of both CFS and FMS, or that the use of nutritional supplements is effective in these patients. Poor study quality and considerable heterogeneity in most studies was found, which makes it difficult to reach a final conclusion. Consistent significant lower circulating concentrations were found repeatedly and in the majority of studies for vitamin A and vitamin E in patients compared to controls. However, the significant difference in circulating concentrations of vitamin E between patients and controls disappeared when excluding low quality studies. None of these or other vitamins and minerals have been repeatedly or consistently linked to clinical parameters. In addition, RCTs testing supplements containing these vitamins and/or minerals did not result in clinical improvements.</p>
<p>This review has several strengths. First, this is the first review focusing on vitamin and mineral deficiencies among CFS and FMS patients. We were able to give a clear overview of the current knowledge existing in literature. Second, we included only studies that examined CFS and FMS patients according to the official diagnostic criteria. We therefore have included relatively homogeneous groups of patients. Third, because we defined strict in- and exclusion criteria, e.g. patients should meet the official diagnostic criteria, or clinical cohorts must have an appropriate control group, poor quality studies were filtered out. Nevertheless, the vast majority of the included studies scored a quality score below a reasonable study quality. Fourth, enough studies that investigated similar vitamins or minerals were available, which made it possible to conduct six meta-analyses. Lastly, we had no language restrictions for the included abstracts or full text articles, which enabled us to include all relevant articles.</p>
<p>We must acknowledge that this study also has its limitations, which are mostly due to limitations in original studies on which this review was based. First, most studies were observational in nature. In general, observational studies have a lower validity than RCTs, and they are more susceptible to bias (e.g. selection and information bias) and confounding factors. Potential confounders were assessed in about half of the studies, but almost no studies adjusted their analyses for potential confounders. Consequently, the results of the current review may be affected by the methodological weaknesses that are accompanied by the observational study designs. Second, quality assessment revealed a poor study quality in the majority of studies. This demonstrates that substantial improvements can be made in terms of study quality, especially in specification of in- and exclusion criteria, presenting disease characteristics of the participants, making use of validated methods to assess vitamin and mineral status, to perform the vitamin and mineral assessments in duplicate, and, as mentioned earlier, to adjust analyses for potential confounders. Furthermore, a quality issue in research on CFS and FMS patients is that of careful selection of control groups. Our quality assessment showed that many included studies fell short because of the selection of the controls, which could result in inaccurate study results. Third, a problem that affects the validity of meta-analyses is the presence of publication bias. Funnel plots indicated the absence of publication bias in the majority of the meta-analyses. Trimming was performed among the calcium studies, and two “missing” studies were added, while no significant funnel plot asymmetry was present. However, trimming was performed in the statistically significant areas, which argues against the presence of publication bias. Although Egger’s test is preferred for more than 10 studies, it revealed significant funnel plot asymmetry in vitamin E, while no trimming was performed. It is therefore possible that the significant outcomes of vitamin E in patients are influenced by publication bias. Lastly, a substantial to considerable heterogeneity in most studies was found, which makes it difficult to reach a final conclusion about vitamin status in CFS and FMS patients.</p>
<p>This review reveals that very few RCTs have investigated the effect of vitamin and mineral supplementation versus placebo in CFS and FMS patients. Most published RCTs found no treatment effect of vitamin and mineral supplementation on clinical parameters. So, the evidence for beneficial effects of supplementation in CFS and FMS patients is not proportional to the large quantity of supplements that are used by these patients. Nevertheless, the industry of vitamin and minerals supplements is increasing, for example, Americans spend an estimated $36.7 billion each year on supplements [<xref ref-type="bibr" rid="pone.0176631.ref077">77</xref>]. This is important information, since the vitamins and minerals in these products are sometimes supplemented in doses high enough to cause side effects, for example gastric discomfort, insomnia, dizziness or weakness [<xref ref-type="bibr" rid="pone.0176631.ref017">17</xref>]. The vast majority of available studies concerned FMS patients. Several FMS studies investigated vitamin D, whereas most CFS studies have focused on vitamin E. Only one CFS study that investigated vitamin E was suitable for inclusion in the meta-analysis. It is remarkable that the significant difference of vitamin E between patients and controls disappeared when the single CFS study was excluded in the sensitivity analysis, while the studies that were not suitable for inclusion in the meta-analysis reported significant lower vitamin E concentrations in particularly CFS patients versus controls. Further research is needed to determine whether this may indicate that vitamin E levels are lower in CFS patients, but not in FMS patients. This systematic review and meta-analysis provides no further insights in whether the remaining vitamins and minerals differ between these two medical conditions.</p>
<p>We conclude that there is little evidence to support the hypothesis that vitamin and mineral deficiencies play a role in the pathophysiology of both CFS and FMS. Furthermore, the current literature on vitamins and minerals in CFS and FMS is of poor quality and stresses the need for well-performed intervention research, and large population-based and age-matched prospective studies in CFS and FMS, in order to gain more insight in the role of vitamins and minerals in the pathophysiology of CFS and FMS. According to our results, potential vitamins and minerals that should be further examined include vitamin A and vitamin E.</p>
</sec>
<sec id="sec023">
<title>Supporting information</title>
<supplementary-material id="pone.0176631.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.s001" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>PRISMA checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0176631.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.s002" xlink:type="simple">
<label>S1 Appendix</label>
<caption>
<title>Search strings.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0176631.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0176631.s003" xlink:type="simple">
<label>S2 Appendix</label>
<caption>
<title>Quality tool to assess methodological quality of vitamin and mineral studies in CFS and FMS.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p><bold>Contributors</bold>: The authors wish to acknowledge the translators of the non-English articles (Léopold Brunet, Jurek Cislo, Anne-Marie Daubigney, Michele Eisenga, Giulia Iozzia, Akin Ozyilmaz, Mehmet Suludere), which made it possible to include all the articles in the current review.</p>
<p><bold>Funders</bold>: The authors received no funding for this work.</p>
<p><bold>Prior presentations</bold>: the European Association for Psychosomatic Medicine (EAPM), 17 June 2016.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>CFS</term>
<def><p>chronic fatigue syndrome</p></def>
</def-item>
<def-item><term>FMS</term>
<def><p>fibromyalgia syndrome</p></def>
</def-item>
<def-item><term>RCT</term>
<def><p>randomized controlled trial</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pone.0176631.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukuda</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Straus</surname> <given-names>SE</given-names></name>, <name name-style="western"><surname>Hickie</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Sharpe</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Dobbins</surname> <given-names>JG</given-names></name>, <name name-style="western"><surname>Komaroff</surname> <given-names>A</given-names></name>. <article-title>The chronic fatigue syndrome: A comprehensive approach to its definition and study</article-title>. <source>Ann Intern Med</source>. <year>1994</year>;<volume>121</volume>(<issue>12</issue>):<fpage>953</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">7978722</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolfe</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Smythe</surname> <given-names>HA</given-names></name>, <name name-style="western"><surname>Yunus</surname> <given-names>MB</given-names></name>, <name name-style="western"><surname>Bennet</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Bombardier</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Goldenberg</surname> <given-names>DL</given-names></name>, <etal>et al</etal>. <article-title>The american college of rheumatology 1990 criteria for the classification of fibromyalgia</article-title>. <source>Arthritis &amp; Rheumatism</source>. <year>1990</year>;<volume>33</volume>(<issue>2</issue>):<fpage>160</fpage>–<lpage>72</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wolfe</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Clauw</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Fitzcharles</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Goldenberg</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Katz</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Mease</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>The american college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity</article-title>. <source>Arthritis care &amp; research</source>. <year>2010</year>;<volume>62</volume>(<issue>5</issue>):<fpage>600</fpage>–<lpage>10</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aaron</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Burke</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Buchwald</surname> <given-names>D</given-names></name>. <article-title>Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder</article-title>. <source>Arch Intern Med</source>. <year>2000</year>;<volume>160</volume>(<issue>2</issue>):<fpage>221</fpage>. <object-id pub-id-type="pmid">10647761</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Janssens</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Zijlema</surname> <given-names>WL</given-names></name>, <name name-style="western"><surname>Joustra</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Rosmalen</surname> <given-names>JG</given-names></name>. <article-title>Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: Results from the LifeLines cohort study</article-title>. <source>Psychosom Med</source>. <year>2015</year>;<volume>77</volume>(<issue>4</issue>), <fpage>449</fpage>–<lpage>457</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/PSY.0000000000000161" xlink:type="simple">10.1097/PSY.0000000000000161</ext-link></comment> <object-id pub-id-type="pmid">25768845</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wessely</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nimnuan</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Sharpe</surname> <given-names>M</given-names></name>. <article-title>Functional somatic syndromes: One or many?</article-title> <source>Lancet</source> <year>1999</year>;<volume>354</volume>(<issue>9182</issue>):<fpage>936</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(98)08320-2" xlink:type="simple">10.1016/S0140-6736(98)08320-2</ext-link></comment> <object-id pub-id-type="pmid">10489969</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Werbach</surname> <given-names>MR</given-names></name>. <article-title>Nutritional strategies for treating chronic fatigue syndrome</article-title>. <source>Altern Med Rev</source>. <year>2000</year>;<volume>5</volume>(<issue>2</issue>):<fpage>93</fpage>–<lpage>108</lpage>. <object-id pub-id-type="pmid">10767667</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arranz</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Canela</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rafecas</surname> <given-names>M</given-names></name>. <article-title>Fibromyalgia and nutrition, what do we know?</article-title> <source>Rheumatol Int</source>. <year>2010</year>;<volume>30</volume>(<issue>11</issue>):<fpage>1417</fpage>–<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00296-010-1443-0" xlink:type="simple">10.1007/s00296-010-1443-0</ext-link></comment> <object-id pub-id-type="pmid">20358204</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lauche</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Cramer</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Häuser</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Dobos</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Langhorst</surname> <given-names>J</given-names></name>. <article-title>A systematic overview of reviews for complementary and alternative therapies in the treatment of the fibromyalgia syndrome</article-title>. <source>Evid Based Complement Alternat Med</source>. <year>2015</year>; <volume>vol. 2015</volume>, Article ID 610615,</mixed-citation></ref>
<ref id="pone.0176631.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grant</surname> <given-names>JE</given-names></name>, <name name-style="western"><surname>Veldee</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Buchwald</surname> <given-names>D</given-names></name>. <article-title>Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome</article-title>. <source>J Am Diet Assoc</source>. <year>1996</year>;<volume>96</volume>(<issue>4</issue>):<fpage>383</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0002-8223(96)00104-6" xlink:type="simple">10.1016/S0002-8223(96)00104-6</ext-link></comment> <object-id pub-id-type="pmid">8598441</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Batista</surname> <given-names>ED</given-names></name>, <name name-style="western"><surname>Andretta</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>de Miranda</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Nehring</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>dos Santos Paiva</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Schieferdecker</surname> <given-names>MEM</given-names></name>. <article-title>Food intake assessment and quality of life in women with fibromyalgia</article-title>. <source>Rev Bras Reumatol (English Edition)</source>. <year>2016</year>;<volume>56</volume>.<issue>2</issue>:<fpage>105</fpage>–<lpage>110</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dykman</surname> <given-names>KD</given-names></name>, <name name-style="western"><surname>Tone</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ford</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Dykman</surname> <given-names>RA</given-names></name>. <article-title>The effects of nutritional supplements on the symptoms of fibromyalgia and chronic fatigue syndrome</article-title>. <source>Integr Physiol Behav Sci</source>. <year>1998</year>;<volume>33</volume>(<issue>1</issue>):<fpage>61</fpage>–<lpage>71</lpage>. <object-id pub-id-type="pmid">9594356</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bennett</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Turk</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Russell</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Matallana</surname> <given-names>L</given-names></name>. <article-title>An internet survey of 2,596 people with fibromyalgia</article-title>. <source>BMC Musculoskelet Disord</source>. <year>2008</year>;<volume>8</volume>(<issue>1</issue>):<fpage>1</fpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wahner-Roedler</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Elkin</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Vincent</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>TH</given-names></name>, <name name-style="western"><surname>Loehrer</surname> <given-names>LL</given-names></name>, <etal>et al</etal>. <article-title>Use of complementary and alternative medical therapies by patients referred to a fibromyalgia treatment program at a tertiary care center</article-title>. <source>Mayo Clin Proc</source>. <year>2005</year>;<volume>80</volume>(<issue>1</issue>):<fpage>55</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0025-6196(11)62958-3" xlink:type="simple">10.1016/S0025-6196(11)62958-3</ext-link></comment> <object-id pub-id-type="pmid">15667030</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>van’t Leven</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zielhuis</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>van der Meer</surname> <given-names>Jos W</given-names></name>, <name name-style="western"><surname>Verbeek</surname> <given-names>AL</given-names></name>, <name name-style="western"><surname>Bleijenberg</surname> <given-names>G</given-names></name>. <article-title>Fatigue and chronic fatigue syndrome-like complaints in the general population</article-title>. <source>Eur J Public Health</source>. <year>2010</year>;<volume>20</volume>(<issue>3</issue>):<fpage>251</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/eurpub/ckp113" xlink:type="simple">10.1093/eurpub/ckp113</ext-link></comment> <object-id pub-id-type="pmid">19689970</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref016"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Van Rossum C, Fransen H, Verkaik-Kloosterman J, Buurma-Rethans E, Ocké M. Dutch national food consumption survey 2007–2010: Diet of children and adults aged 7 to 69 years. 2011;RIVM rapport 350050006.</mixed-citation></ref>
<ref id="pone.0176631.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Halsted</surname> <given-names>CH</given-names></name>. <article-title>Dietary supplements and functional foods: 2 sides of a coin?</article-title> <source>Am J Clin Nutr</source>. <year>2003</year>;<volume>77</volume>(<issue>4 Suppl</issue>):<fpage>1001S</fpage>–<lpage>7S</lpage>. <object-id pub-id-type="pmid">12663307</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chang</surname> <given-names>K</given-names></name>. <article-title>Is serum hypovitaminosis D associated with chronic widespread pain including fibromyalgia? A meta-analysis of observational studies</article-title>. <source>Pain physicia</source> <year>2015</year>;<volume>18</volume>:<fpage>E877</fpage>–<lpage>87</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Liberati</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tetzlaff</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement</article-title>. <source>Ann Intern Med</source>. <year>2009</year>;<volume>151</volume>(<issue>4</issue>):<fpage>264</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">19622511</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Gotzsche</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Jüni</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Moher</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Oxman</surname> <given-names>AD</given-names></name>, <etal>et al</etal>. <article-title>The cochrane collaboration's tool for assessing risk of bias in randomised trials</article-title>. <source>BMJ</source>. <year>2011</year>;<volume>343</volume>:<fpage>d5928</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.d5928" xlink:type="simple">10.1136/bmj.d5928</ext-link></comment> <object-id pub-id-type="pmid">22008217</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sanderson</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tatt</surname> <given-names>ID</given-names></name>, <name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>. <article-title>Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: A systematic review and annotated bibliography</article-title>. <source>Int J Epidemiol</source>. <year>2007</year>;<volume>36</volume>(<issue>3</issue>):<fpage>666</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/ije/dym018" xlink:type="simple">10.1093/ije/dym018</ext-link></comment> <object-id pub-id-type="pmid">17470488</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Dinnes</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>D’amico</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Sowden</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Sakarovitch</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Song</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Evaluating non-randomised intervention studies</article-title>. <source>Health Technol Assess</source>. <year>2003</year>;<volume>7</volume>(<issue>27</issue>):<fpage>1</fpage>–<lpage>179</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tak</surname> <given-names>LM</given-names></name>, <name name-style="western"><surname>Riese</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>de Bock</surname> <given-names>GH</given-names></name>, <name name-style="western"><surname>Manoharan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kok</surname> <given-names>IC</given-names></name>, <name name-style="western"><surname>Rosmalen</surname> <given-names>JG</given-names></name>. <article-title>As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders</article-title>. <source>Biol Psychol</source>. <year>2009</year>;<volume>82</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>10</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.biopsycho.2009.05.002" xlink:type="simple">10.1016/j.biopsycho.2009.05.002</ext-link></comment> <object-id pub-id-type="pmid">19463887</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Von Elm</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pocock</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Gøtzsche</surname> <given-names>PC</given-names></name>, <name name-style="western"><surname>Vandenbroucke</surname> <given-names>JP</given-names></name>, <etal>et al</etal>. <article-title>The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies</article-title>. <source>Prev Med</source>. <year>2007</year>;<volume>45</volume>(<issue>4</issue>):<fpage>247</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ypmed.2007.08.012" xlink:type="simple">10.1016/j.ypmed.2007.08.012</ext-link></comment> <object-id pub-id-type="pmid">17950122</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Lyman</surname> <given-names>GH</given-names></name>. <article-title>Methodological challenges in the evaluation of prognostic factors in breast cancer</article-title>. <source>Breast Cancer Res Treat</source>. <year>1998</year>;<volume>52</volume>(<issue>1–3</issue>):<fpage>289</fpage>–<lpage>303</lpage>. <object-id pub-id-type="pmid">10066088</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Siegfried</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Muller</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Volmink</surname> <given-names>J</given-names></name>. <article-title>Male circumcision for prevention of heterosexual acquisition of HIV in men</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2009</year>;<volume>2</volume>.</mixed-citation></ref>
<ref id="pone.0176631.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Patra</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bhatia</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Suraweera</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Morris</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Patra</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Gupta</surname> <given-names>PC</given-names></name>, <etal>et al</etal>. <article-title>Exposure to second-hand smoke and the risk of tuberculosis in children and adults: A systematic review and meta-analysis of 18 observational studies</article-title>. <source>PLoS Med</source>. <year>2015</year>;<volume>12</volume>(<issue>6</issue>):<fpage>e1001835</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pmed.1001835" xlink:type="simple">10.1371/journal.pmed.1001835</ext-link></comment> <object-id pub-id-type="pmid">26035557</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>;<volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>–<lpage>34</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>R</given-names></name>. <article-title>Trim and fill: A simple funnel‐plot—based method of testing and adjusting for publication bias in meta-analysis</article-title>. <source>Biometrics</source>. <year>2000</year>;<volume>56</volume>(<issue>2</issue>):<fpage>455</fpage>–<lpage>63</lpage>. <object-id pub-id-type="pmid">10877304</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peters</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Sutton</surname> <given-names>AJ</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Abrams</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Rushton</surname> <given-names>L</given-names></name>. <article-title>Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry</article-title>. <source>J Clin Epidemiol</source>. <year>2008</year>;<volume>61</volume>(<issue>10</issue>):<fpage>991</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jclinepi.2007.11.010" xlink:type="simple">10.1016/j.jclinepi.2007.11.010</ext-link></comment> <object-id pub-id-type="pmid">18538991</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brennan</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Silman</surname> <given-names>A</given-names></name>. <article-title>Statistical methods for assessing observer variability in clinical measures</article-title>. <source>BMJ</source>. <year>1992</year>;<volume>304</volume>(<issue>6840</issue>):<fpage>1491</fpage>–<lpage>4</lpage>. <object-id pub-id-type="pmid">1611375</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akkuş</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Nazıroğlu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eriş</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Yalman</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yılmaz</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Yener</surname> <given-names>M</given-names></name>. <article-title>Levels of lipid peroxidation, nitric oxide, and antioxidant vitamins in plasma of patients with fibromyalgia</article-title>. <source>Cell Biochem Funct</source>. <year>2009</year>;<volume>27</volume>(<issue>4</issue>):<fpage>181</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/cbf.1548" xlink:type="simple">10.1002/cbf.1548</ext-link></comment> <object-id pub-id-type="pmid">19319826</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Al-Allaf</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Mole</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Paterson</surname> <given-names>CR</given-names></name>, <name name-style="western"><surname>Pullar</surname> <given-names>T</given-names></name>. <article-title>Bone health in patients with fibromyalgia</article-title>. <source>Rheumatology (Oxford)</source>. <year>2003</year>;<volume>42</volume>(<issue>10</issue>):<fpage>1202</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bagis</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Karabiber</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>As</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Tamer</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Erdogan</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Atalay</surname> <given-names>A</given-names></name>. <article-title>Is magnesium citrate treatment effective on pain, clinical parameters and functional status in patients with fibromyalgia?</article-title> <source>Rheumatol Int</source>. <year>2013</year>;<volume>33</volume>(<issue>1</issue>):<fpage>167</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00296-011-2334-8" xlink:type="simple">10.1007/s00296-011-2334-8</ext-link></comment> <object-id pub-id-type="pmid">22271372</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baygutalp</surname> <given-names>NK</given-names></name>, <name name-style="western"><surname>Baygutalp</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Seferoğlu</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Bakan</surname> <given-names>E</given-names></name>. <article-title>Serum vitamin D seviyelerinin fibromiyalji sendromunun klinik bulguları ile ilişkisi (The relation between serum vitamin D levels and clinical findings of fibromyalgia syndrome)</article-title>. <source>Dicle Tıp Dergisi</source>. <year>2014</year>;<volume>41</volume>(<issue>3</issue>):<fpage>446</fpage>–<lpage>450</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bazzichi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Giannaccini</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Betti</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Fabbrini</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Schmid</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Palego</surname> <given-names>L</given-names></name>. <article-title>ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia</article-title>. <source>Clin Biochem</source>. <year>2008</year>;<volume>41</volume>(<issue>13</issue>):<fpage>1084</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.clinbiochem.2008.06.012" xlink:type="simple">10.1016/j.clinbiochem.2008.06.012</ext-link></comment> <object-id pub-id-type="pmid">18634773</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brouwers</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Van Der Werf</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bleijenberg</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Van Der Zee</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Van Der Meer</surname> <given-names>JW</given-names></name>. <article-title>The effect of a polynutrient supplement on fatigue and physical activity of patients with chronic fatigue syndrome: A double-blind randomized controlled trial</article-title>. <source>QJM</source>. <year>2002</year>;<volume>95</volume>(<issue>10</issue>):<fpage>677</fpage>–<lpage>83</lpage>. <object-id pub-id-type="pmid">12324640</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Costa</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Ranzolin</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Costa Neto</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Marques</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Duarte</surname> <given-names>AL</given-names></name>. <article-title>High frequency of asymptomatic hyperparathyroidism in patients with fibromyalgia: random association or misdiagnosis?</article-title> <source>Rev Bras Reumatol</source>. <year>2016</year>;<volume>56</volume>(<issue>5</issue>):<fpage>391</fpage>–<lpage>397</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eisinger</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gandolfo</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zakarian</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ayavou</surname> <given-names>T</given-names></name>. <article-title>Reactive oxygen species, antioxidant status and fibromyalgia</article-title>. <source>J Musculoskeletal Pain</source>. <year>1997</year>;<volume>5</volume>(<issue>4</issue>):<fpage>5</fpage>–<lpage>15</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Eisinger</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zakarian</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Pouly</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Plantamura</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ayavou</surname> <given-names>T</given-names></name>. <article-title>Protein peroxidation, magnesium deficiency and fibromyalgia</article-title>. <source>Magnes Res</source>. <year>1996</year>;<volume>9</volume>(<issue>4</issue>):<fpage>313</fpage>–<lpage>6</lpage>. <object-id pub-id-type="pmid">9247880</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heidari</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Shirvani</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Firouzjahi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Heidari</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hajian-Tilaki</surname> <given-names>KO</given-names></name>. <article-title>Association between nonspecific skeletal pain and vitamin D deficiency</article-title>. <source>Int J Rheum Dis</source>. <year>2010</year>;<volume>13</volume>(<issue>4</issue>):<fpage>340</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1756-185X.2010.01561.x" xlink:type="simple">10.1111/j.1756-185X.2010.01561.x</ext-link></comment> <object-id pub-id-type="pmid">21199469</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jammes</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Steinberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Delliaux</surname> <given-names>S</given-names></name>. <article-title>Chronic fatigue syndrome: Acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins</article-title>. <source>J Intern Med</source>. <year>2012</year>;<volume>272</volume>(<issue>1</issue>):<fpage>74</fpage>–<lpage>84</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2796.2011.02488.x" xlink:type="simple">10.1111/j.1365-2796.2011.02488.x</ext-link></comment> <object-id pub-id-type="pmid">22112145</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jammes</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Steinberg</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Delliaux</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Brégeon</surname> <given-names>F</given-names></name>. <article-title>Chronic fatigue syndrome combines increased exercise‐induced oxidative stress and reduced cytokine and hsp responses</article-title>. <source>J Intern Med</source>. <year>2009</year>;<volume>266</volume>(<issue>2</issue>):<fpage>196</fpage>–<lpage>206</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2796.2009.02079.x" xlink:type="simple">10.1111/j.1365-2796.2009.02079.x</ext-link></comment> <object-id pub-id-type="pmid">19457057</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kasapoğlu Aksoy</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Altan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ökmen Metin</surname> <given-names>B</given-names></name>. <article-title>The relationship between balance and vitamin 25 (OH) D in fibromyalgia patients</article-title>. <source>Mod Rheumatol</source>. <year>2016</year>: <fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khalifa</surname> <given-names>II</given-names></name>, <name name-style="western"><surname>Hassan</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>AL-Deri</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Gorial</surname> <given-names>FI</given-names></name>. <article-title>Determination of Some Essential &amp; Non-Essential Metals in Patients with Fibromyalgia Syndrome (FMS)</article-title>. <source>IJPSR</source>. <year>2016</year>;<volume>8</volume>(<issue>5</issue>):<fpage>306</fpage>–<lpage>311</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>BT</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Cho</surname> <given-names>DY</given-names></name>, <etal>et al</etal>. <article-title>Women with fibromyalgia have lower levels of calcium, magnesium, iron and manganese in hair mineral analysis</article-title>. <source>J Korean Med Sci</source>. <year>2011</year>;<volume>26</volume>(<issue>10</issue>):<fpage>1253</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3346/jkms.2011.26.10.1253" xlink:type="simple">10.3346/jkms.2011.26.10.1253</ext-link></comment> <object-id pub-id-type="pmid">22022174</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kurup</surname> <given-names>RK</given-names></name>, <name name-style="western"><surname>Kurup</surname> <given-names>PA</given-names></name>. <article-title>Isoprenoid pathway dysfunction in chronic fatigue syndrome</article-title>. <source>Acta Neuropsychiatr</source>. <year>2003</year>;<volume>15</volume>(<issue>5</issue>):<fpage>266</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1034/j.1601-5215.2003.00045.x" xlink:type="simple">10.1034/j.1601-5215.2003.00045.x</ext-link></comment> <object-id pub-id-type="pmid">26983655</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>La Rubia</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Rus</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Molina</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Del Moral</surname> <given-names>ML</given-names></name>. <article-title>Is fibromyalgia-related oxidative stress implicated in the decline of physical and mental health status?</article-title> <source>Clin Exp Rheumatol</source>. <year>2013</year>;<volume>31</volume>(<issue>6 Suppl 79</issue>):<fpage>S121</fpage>–<lpage>7</lpage>. <object-id pub-id-type="pmid">24373370</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maafi</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Ghavidel-Parsa</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Haghdoost</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Aarabi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Hajiabbasi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Shenavar Masooleh</surname> <given-names>I</given-names></name>, <etal>et al</etal>. <article-title>Serum Vitamin D Status in Iranian Fibromyalgia Patients: according to the Symptom Severity and Illness Invalidation</article-title>. <source>Korean J Pain</source>. <year>2016</year>;<volume>29</volume>(<issue>3</issue>):<fpage>172</fpage>–<lpage>178</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3344/kjp.2016.29.3.172" xlink:type="simple">10.3344/kjp.2016.29.3.172</ext-link></comment> <object-id pub-id-type="pmid">27413482</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mader</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Koton</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Buskila</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Herer</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Elias</surname> <given-names>M</given-names></name>. <article-title>Serum iron and iron stores in non-anemic patients with fibromyalgia</article-title>. <source>Clin Rheumatol</source>. <year>2012</year>;<volume>31</volume>(<issue>4</issue>):<fpage>595</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10067-011-1888-x" xlink:type="simple">10.1007/s10067-011-1888-x</ext-link></comment> <object-id pub-id-type="pmid">22095117</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maes</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mihaylova</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>De Ruyter</surname> <given-names>M</given-names></name>. <article-title>Lower serum zinc in chronic fatigue syndrome (CFS): Relationships to immune dysfunctions and relevance for the oxidative stress status in CFS</article-title>. <source>J Affect Disord</source>. <year>2006</year>;<volume>90</volume>(<issue>2</issue>):<fpage>141</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mateos</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Valero</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Olmos</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Casanueva</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Castillo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Martínez</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Bone mass and vitamin D levels in women with a diagnosis of fibromyalgia</article-title>. <source>Osteoporosis Int</source>. <year>2014</year>;<volume>25</volume>(<issue>2</issue>):<fpage>525</fpage>–<lpage>33</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McCully</surname> <given-names>KK</given-names></name>, <name name-style="western"><surname>Malucelli</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Iotti</surname> <given-names>S</given-names></name>. <article-title>Increase of free Mg2+ in the skeletal muscle of chronic fatigue syndrome patients</article-title>. <source>Dyn Med</source>. <year>2006</year>;<volume>5</volume>(<issue>1</issue>):<fpage>1</fpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mechtouf</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Jacob</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zakarian</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ayavou</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Eisinger</surname> <given-names>J</given-names></name>. <article-title>Vitamin B1 abnormalities in persons with fibromyalgia, myofascial pain syndrome and chronic alcoholism</article-title>. <source>Lyon Mediterr Med Med Sud-Est</source>. <year>1998</year>;<volume>34</volume>(<issue>3–4</issue>):<fpage>28</fpage>–<lpage>31</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miwa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Fujita</surname> <given-names>M</given-names></name>. <article-title>Fluctuation of serum vitamin E (α-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome</article-title>. <source>Heart Vessels</source>. <year>2010</year>;<volume>25</volume>(<issue>4</issue>):<fpage>319</fpage>–<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00380-009-1206-6" xlink:type="simple">10.1007/s00380-009-1206-6</ext-link></comment> <object-id pub-id-type="pmid">20676841</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miwa</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Fujita</surname> <given-names>M</given-names></name>. <article-title>Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome</article-title>. <source>Int J Cardiol</source>. <year>2008</year>;<volume>136</volume>(<issue>2</issue>):<fpage>238</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijcard.2008.04.051" xlink:type="simple">10.1016/j.ijcard.2008.04.051</ext-link></comment> <object-id pub-id-type="pmid">18684522</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nazıroğlu</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Akkuş</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Soyupek</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Yalman</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Çelik</surname> <given-names>Ö</given-names></name>, <name name-style="western"><surname>Eriş</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Vitamins C and E treatment combined with exercise modulates oxidative stress markers in blood of patients with fibromyalgia: A controlled clinical pilot study</article-title>. <source>Stress</source>. <year>2010</year>;<volume>13</volume>(<issue>6</issue>):<fpage>498</fpage>–<lpage>505</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3109/10253890.2010.486064" xlink:type="simple">10.3109/10253890.2010.486064</ext-link></comment> <object-id pub-id-type="pmid">20666654</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ng</surname> <given-names>SY</given-names></name>. <article-title>Hair calcium and magnesium levels in patients with fibromyalgia: A case center study</article-title>. <source>J Manipulative Physiol Ther</source>. <year>1999</year>;<volume>22</volume>(<issue>9</issue>):<fpage>586</fpage>–<lpage>93</lpage>. <object-id pub-id-type="pmid">10626702</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nørregaard</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Btilow</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mehlsen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Danneskiold‐Samsøe</surname> <given-names>B</given-names></name>. <article-title>Biochemical changes in relation to a maximal exercise test in patients with fibromyalgia</article-title>. <source>Clin Physiol</source>. <year>1994</year>;<volume>14</volume>(<issue>2</issue>):<fpage>159</fpage>–<lpage>67</lpage>. <object-id pub-id-type="pmid">8205747</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Okyay</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Koçyiğit</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Gürsoy</surname> <given-names>S</given-names></name>. <article-title>Vitamin D Levels in Women with Fibromyalgia and Relationship between Pain, Tender Point Count and Disease Activity</article-title>. <source>Acta Medica Mediterranea</source>. <year>2016</year>;<volume>32</volume>(<issue>1</issue>): <fpage>243</fpage>–<lpage>247</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Olama</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Senna</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Elarman</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Elhawary</surname> <given-names>G</given-names></name>. <article-title>Serum vitamin D level and bone mineral density in premenopausal egyptian women with fibromyalgia</article-title>. <source>Rheumatol Int</source>. <year>2013</year>;<volume>33</volume>(<issue>1</issue>):<fpage>185</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00296-012-2361-0" xlink:type="simple">10.1007/s00296-012-2361-0</ext-link></comment> <object-id pub-id-type="pmid">22311432</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ortancil</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Sanli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Eryuksel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Basaran</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ankarali</surname> <given-names>H</given-names></name>. <article-title>Association between serum ferritin level and fibromyalgia syndrome</article-title>. <source>Eur J Clin Nutr</source>. <year>2010</year>;<volume>64</volume>(<issue>3</issue>):<fpage>308</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ejcn.2009.149" xlink:type="simple">10.1038/ejcn.2009.149</ext-link></comment> <object-id pub-id-type="pmid">20087382</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Özcan</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Oken</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Aras</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Koseoglu</surname> <given-names>BF</given-names></name>. <article-title>Fibromiyaljili kadin hastalarda vitamin D duzeyleri ve agri, depresyon, uyku ile iliskisi (Vitamin D levels in women with fibromyalgia and relationship between pain, depression, and sleep)</article-title>. <source>Turkish J Phys Med and Rehab</source>. <year>2014</year>;<volume>60</volume>(<issue>4</issue>):<fpage>329</fpage>–<lpage>335</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reinhard</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Schweinsberg</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wernet</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Kötter</surname> <given-names>I</given-names></name>. <article-title>Selenium status in fibromyalgia</article-title>. <source>Toxicol Lett</source>. <year>1998</year>;<volume>96</volume>:<fpage>177</fpage>–<lpage>80</lpage>. <object-id pub-id-type="pmid">9820664</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rezende Pena</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Grillo</surname> <given-names>LP</given-names></name>, <name name-style="western"><surname>das Chagas Medeiros</surname> <given-names>MM</given-names></name>. <article-title>Evaluation of 25-hydroxyvitamin D serum levels in patients with fibromyalgia</article-title>. <source>J Clin Rheumatol</source>. <year>2010</year>;<volume>16</volume>(<issue>8</issue>):<fpage>365</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/RHU.0b013e3181fe8a90" xlink:type="simple">10.1097/RHU.0b013e3181fe8a90</ext-link></comment> <object-id pub-id-type="pmid">21085020</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rosborg</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hyllén</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Lidbeck</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nihlgård</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Gerhardsson</surname> <given-names>L</given-names></name>. <article-title>Trace element pattern in patients with fibromyalgia</article-title>. <source>Sci Total Environ</source>. <year>2007</year>;<volume>385</volume>(<issue>1</issue>):<fpage>20</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakarya</surname> <given-names>ST</given-names></name>, <name name-style="western"><surname>Akyol</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Bedir</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Canturk</surname> <given-names>F</given-names></name>. <article-title>The relationship between serum antioxidant vitamins, magnesium levels, and clinical parameters in patients with primary fibromyalgia syndrome</article-title>. <source>Clin Rheumatol</source>. <year>2011</year>;<volume>30</volume>(<issue>8</issue>):<fpage>1039</fpage>–<lpage>43</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10067-011-1697-2" xlink:type="simple">10.1007/s10067-011-1697-2</ext-link></comment> <object-id pub-id-type="pmid">21347604</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Samborski</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Stratz</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Lacki</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Mackiewicz</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Mueller</surname> <given-names>W</given-names></name>. <article-title>The serum concentration of calcitonin in patients with fibromyalgia—new therapeutic approach?</article-title> <source>Reumatologia (Warsaw)</source>. <year>1997</year>;<volume>35</volume>(<issue>2</issue>):<fpage>160</fpage>–<lpage>5</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sendur</surname> <given-names>OF</given-names></name>, <name name-style="western"><surname>Tastaban</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Turan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ulman</surname> <given-names>C</given-names></name>. <article-title>The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia</article-title>. <source>Rheumatol Int</source>. <year>2008</year>;<volume>28</volume>(<issue>11</issue>):<fpage>1117</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00296-008-0593-9" xlink:type="simple">10.1007/s00296-008-0593-9</ext-link></comment> <object-id pub-id-type="pmid">18496697</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tandeter</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Grynbaum</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zuili</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Shany</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Shvartzman</surname> <given-names>P</given-names></name>. <article-title>Serum 25-OH vitamin D levels in patients with fibromyalgia</article-title>. <source>Isr Med Assoc J</source>. <year>2009</year>;<volume>11</volume>(<issue>6</issue>):<fpage>339</fpage>–<lpage>42</lpage>. <object-id pub-id-type="pmid">19697583</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turkyilmaz</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Yalcinkaya</surname> <given-names>EY</given-names></name>, <name name-style="western"><surname>Ones</surname> <given-names>K</given-names></name>. <article-title>The effects of bone mineral density and level of serum vitamin-D on pain and quality of life in fibromialgia patients (Fibromiyalji hastalarinda kemik mineral yogunlugu ile serum D vitamini duzeyinin agri ve yasam kalitesi uzerine etkisi)</article-title>. <source>From the Osteoporosis World</source>. <year>2010</year>; <fpage>53</fpage>–<lpage>58</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ulusoy</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Sarica</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Arslan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ozyurt</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Cetin</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Birgul</surname> <given-names>OE</given-names></name>, <etal>et al</etal>. <article-title>Serum vitamin D status and bone mineral density in fibromyalgia</article-title>. <source>Bratisl Lek Listy</source>. <year>2010</year>;<volume>111</volume>(<issue>11</issue>):<fpage>604</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">21384747</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vecchiet</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cipollone</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Falasca</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Mezzetti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Pizzigallo</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bucciarelli</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome</article-title>. <source>Neurosci Lett</source>. <year>2003</year>;<volume>335</volume>(<issue>3</issue>):<fpage>151</fpage>–<lpage>4</lpage>. <object-id pub-id-type="pmid">12531455</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wepner</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Scheuer</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Schuetz-Wieser</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Machacek</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Pieler-Bruha</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Cross</surname> <given-names>HS</given-names></name>, <etal>et al</etal>. <article-title>Effects of vitamin D on patients with fibromyalgia syndrome: A randomized placebo-controlled trial</article-title>. <source>PAIN<sup>®</sup></source>. <year>2014</year>;<volume>155</volume>(<issue>2</issue>):<fpage>261</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Witham</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Adams</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>McSwiggan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kennedy</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kabir</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Belch</surname> <given-names>JJF</given-names></name>, <etal>et al</etal>. <article-title>Effect of intermittent vitamin D3 on vascular function and symptoms in chronic fatigue syndrome—A randomised controlled trial</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. <year>2015</year>;<volume>25</volume>(<issue>3</issue>):<fpage>287</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.numecd.2014.10.007" xlink:type="simple">10.1016/j.numecd.2014.10.007</ext-link></comment> <object-id pub-id-type="pmid">25455721</object-id></mixed-citation></ref>
<ref id="pone.0176631.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yildirim</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Solmaz</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Akgol</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ersoy</surname> <given-names>Y</given-names></name>. <article-title>Relationship between mean platelet volume and vitamin D deficiency in fibromyalgia</article-title>. <source>Biomed Res</source>. <year>2016</year>;<volume>27</volume>(<issue>4</issue>): <fpage>1265</fpage>–<lpage>1270</lpage>.</mixed-citation></ref>
<ref id="pone.0176631.ref077"><label>77</label><mixed-citation publication-type="other" xlink:type="simple">Nutrition Business Journal. NBJ's supplement business report: An analysis of markets, trends, competition and strategy in the U.S. dietary supplement industry. New York: Penton Media, 2011.</mixed-citation></ref>
</ref-list>
</back>
</article>